JP2018025752A - Optical anisotropic body - Google Patents

Optical anisotropic body Download PDF

Info

Publication number
JP2018025752A
JP2018025752A JP2017113403A JP2017113403A JP2018025752A JP 2018025752 A JP2018025752 A JP 2018025752A JP 2017113403 A JP2017113403 A JP 2017113403A JP 2017113403 A JP2017113403 A JP 2017113403A JP 2018025752 A JP2018025752 A JP 2018025752A
Authority
JP
Japan
Prior art keywords
oco
coo
group
formula
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017113403A
Other languages
Japanese (ja)
Other versions
JP6933004B2 (en
Inventor
雅弘 堀口
Masahiro Horiguchi
雅弘 堀口
清香 野瀬
Sayaka Nose
清香 野瀬
桑名 康弘
Yasuhiro Kuwana
康弘 桑名
浩一 延藤
Koichi Nobuto
浩一 延藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIC Corp
Original Assignee
DIC Corp
Dainippon Ink and Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIC Corp, Dainippon Ink and Chemicals Co Ltd filed Critical DIC Corp
Priority to US15/668,235 priority Critical patent/US10655066B2/en
Publication of JP2018025752A publication Critical patent/JP2018025752A/en
Application granted granted Critical
Publication of JP6933004B2 publication Critical patent/JP6933004B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Liquid Crystal (AREA)
  • Laminated Bodies (AREA)
  • Polarising Elements (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an optical film that has a little alignment defect and prevents the occurrence of a change in optical characteristic when placed in a high temperature state.SOLUTION: The invention of the present application provided an optical film that includes a structural unit derived from a specific compound, that is, the invention of the present application provides an optical film that includes a structural unit derived from a compound represented by the general formula (I), has a little alignment defect, and prevents the occurrence of a change in optical characteristic when placed in a high temperature state, and provides a display using the optical film as well.SELECTED DRAWING: None

Description

本発明は光学フィルム、当該光学フィルムを用いた表示装置に関する。   The present invention relates to an optical film and a display device using the optical film.

重合性基を有する化合物(重合性化合物)は種々のフィルムの原料として使用される。例えば、重合性化合物を含む重合性組成物を液晶状態で配列させた後、重合させることにより、均一な配向を有するフィルム状の重合体を作製することが可能である。このようにして作製したフィルムは、ディスプレイに必要な偏光板、位相差板等に使用することができる。多くの場合、要求される光学特性、重合速度、溶解性、融点、ガラス転移温度、フィルムの透明性、機械的強度、表面硬度、耐熱性及び耐光性を満たすために、2種類以上の重合性化合物を含む重合性組成物が使用される。その際、使用する重合性化合物には、他の特性に悪影響を及ぼすことなく、重合性組成物に良好な物性をもたらすことが求められる。また、このような重合性組成物にキラル化合物を添加し、重合性組成物をコレステリック液晶状態で配列させた後、重合させることによって、コレステリック構造を有するフィルムを作製することができる。 コレステリック構造を有するフィルムの作製を目的とする場合、広い温度範囲で液晶相として存在でき、かつ高いコレステリック配向性を有する重合性化合物が必要である。また、工業的に重合性液晶組成物を使用する際は、長時間保管しても成分中の重合性化合物が析出することが無いよう、高い保存安定性が求められる。   A compound having a polymerizable group (polymerizable compound) is used as a raw material for various films. For example, it is possible to prepare a film-like polymer having a uniform orientation by arranging a polymerizable composition containing a polymerizable compound in a liquid crystal state and then polymerizing it. Thus, the produced film can be used for a polarizing plate, a phase difference plate, etc. which are required for a display. In many cases, two or more types of polymerizability are required to satisfy the required optical properties, polymerization rate, solubility, melting point, glass transition temperature, film transparency, mechanical strength, surface hardness, heat resistance and light resistance. A polymerizable composition containing the compound is used. In that case, the polymerizable compound to be used is required to bring good physical properties to the polymerizable composition without adversely affecting other properties. Moreover, a film having a cholesteric structure can be produced by adding a chiral compound to such a polymerizable composition, arranging the polymerizable composition in a cholesteric liquid crystal state, and then polymerizing. For the purpose of producing a film having a cholesteric structure, a polymerizable compound that can exist as a liquid crystal phase in a wide temperature range and has high cholesteric orientation is required. In addition, when the polymerizable liquid crystal composition is used industrially, high storage stability is required so that the polymerizable compound in the component does not precipitate even when stored for a long time.

当該コレステリック構造を有するフィルムを表示装置等の光学フィルムとして使用する場合、配向欠陥が少なく、高温状態に置かれた場合に選択反射波長の変化量が少ないことが求められる。しかしながら、従来知られていた材料は、重合性コレステリック液晶組成物を調製しフィルムを作製した場合に、配向欠陥が生じたり、フィルムを高温下で保管した場合に選択反射波長が大きく変化してしまったりする問題があった(特許文献1、2)。配向欠陥が生じやすかったり選択反射波長が変化しやすかったりするフィルムを、例えばディスプレイに使用した場合、長期間の使用によって画面の明るさが不均一となってしまったり、色味が不自然となってしまったり、目的の光学特性が得られなくなったりしてしまい、ディスプレイ製品の品質を大きく低下させてしまう問題があった。   When the film having the cholesteric structure is used as an optical film for a display device or the like, it is required that there are few orientation defects and the change amount of the selective reflection wavelength is small when placed in a high temperature state. However, conventionally known materials have alignment defects when a polymerizable cholesteric liquid crystal composition is prepared and a film is produced, and the selective reflection wavelength changes greatly when the film is stored at a high temperature. There was a problem of being uncertain (Patent Documents 1 and 2). When a film that easily causes orientation defects or changes the selective reflection wavelength, for example, is used for a display, the brightness of the screen becomes uneven or the color becomes unnatural due to long-term use. Or the target optical characteristics cannot be obtained, and the quality of the display product is greatly deteriorated.

また、ディスプレイ等の光学補償用に使用される位相差板においては、配向欠陥が少なく、高温状態に置かれた場合に位相差の変化量が少ないことが求められる。しかしながら、従来知られていた材料は、重合性液晶組成物を調製しフィルムを作製した場合に、配向欠陥が生じたり、フィルムを高温下で保管した場合に位相差が大きく変化してしまったりする問題があった(特許文献1、2)。   In addition, a retardation plate used for optical compensation such as a display is required to have few alignment defects and a small amount of change in retardation when placed in a high temperature state. However, conventionally known materials may cause alignment defects when a polymerizable liquid crystal composition is prepared to produce a film, or the phase difference may change greatly when the film is stored at a high temperature. There was a problem (Patent Documents 1 and 2).

WO2005/054406A1号公報WO2005 / 054406A1 WO2016/047648A1号公報WO2016 / 047648A1 publication

本発明が解決しようとする課題は、配向欠陥が少なく、高温状態に置かれた場合に光学特性の変化が生じにくい光学フィルムを提供することである。   The problem to be solved by the present invention is to provide an optical film that has few alignment defects and hardly changes in optical characteristics when placed in a high temperature state.

本発明者らは、上記課題を解決すべく、鋭意研究を行った結果、特定の化合物に由来する構造単位を含有する光学フィルムの開発に至った。すなわち、本願発明は一般式(I)で表される化合物に由来する構造単位を含有する光学フィルムを提供し、併せて当該光学フィルムを用いた表示装置を提供する。   As a result of intensive studies to solve the above problems, the present inventors have led to the development of an optical film containing a structural unit derived from a specific compound. That is, this invention provides the optical film containing the structural unit derived from the compound represented by general formula (I), and also provides the display apparatus using the said optical film.

本願発明の光学フィルムは、配向欠陥が少なく、高温状態に置かれた場合に光学特性の変化が生じにくいことから、表示装置用途の位相差フィルム、選択反射フィルム等として有用である。   The optical film of the present invention is useful as a retardation film, a selective reflection film and the like for display devices because it has few alignment defects and hardly changes in optical characteristics when placed in a high temperature state.

本願発明は特定の化合物に由来する構造単位を含有する光学フィルムを提供し、併せて当該光学フィルムを用いた表示装置を提供する。   The present invention provides an optical film containing a structural unit derived from a specific compound, and also provides a display device using the optical film.

本願発明の光学フィルムは、下記の一般式(I)で表される化合物に由来する構造単位を含有する。   The optical film of the present invention contains a structural unit derived from a compound represented by the following general formula (I).

Figure 2018025752
Figure 2018025752

(式中、Pは下記の式(P−1)から式(P−20) (In the formula, P 1 is the following formula (P-1) to formula (P-20)

Figure 2018025752
Figure 2018025752

から選ばれる基を表し、
S1は1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子又は塩素原子に置換されても良く、
Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、
k1は0から10の整数を表し、
n11及びn12は各々独立して0から8の整数を表し、
は水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、イソシアノ基、チオイソシアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、Rは下記の式(I−R2)
Represents a group selected from
In R S1 , one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO. -S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH A linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by ═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— or —C≡C— In which any hydrogen atom in the alkyl group may be substituted with a fluorine atom or a chlorine atom,
Sp 1 represents an alkylene group having 1 to 20 carbon atoms, and when a plurality of Sp 1 are present, they may be the same or different,
X 1 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO. -O -, - CO-NH - , - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, — CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH- , -N = N -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, X 1 is more present They may be different even in the same case that,
k1 represents an integer of 0 to 10,
n11 and n12 each independently represents an integer of 0 to 8,
R 2 is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, an isocyano group, a thioisocyano group, or any hydrogen atom in the group is a fluorine atom. One —CH 2 — or two or more non-adjacent —CH 2 — may be each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—, —NH—CO—, —SCH 2 —, — CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH— , -OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 C 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - Linear or branched having 1 to 20 carbon atoms which may be substituted by CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C— Represents an alkyl group, or R 2 represents the following formula (I-R2)

Figure 2018025752
Figure 2018025752

(式中、Pは上記の式(P−1)から式(P−20)から選ばれる基を表し、
S2は1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子又は塩素原子に置換されても良く、
Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、
k2は0から10の整数を表し、
n21及びn22は各々独立して0から8の整数を表す。)
但し、一般式(I)に−O−O−結合は含まない。
(Wherein P 2 represents a group selected from the above formulas (P-1) to (P-20);
R S2 represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO. -S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH A linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by ═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— or —C≡C— In which any hydrogen atom in the alkyl group may be substituted with a fluorine atom or a chlorine atom,
Sp 2 represents an alkylene group having 1 to 20 carbon atoms, and when a plurality of Sp 2 are present, they may be the same or different,
X 2 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO. -O -, - CO-NH - , - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, — CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH- , -N = N -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, X 2 is plurality of They may be different even in the same case that,
k2 represents an integer of 0 to 10,
n21 and n22 each independently represents an integer of 0 to 8. )
However, the general formula (I) does not include an —O—O— bond.

一般式(I)において、P及び存在するPは式(P−1)から式(P−20)から選ばれる基を表すが、特に重合方法として紫外線重合を行う場合には、式(P−1)、式(P−2)、式(P−3)、式(P−4)、式(P−5)、式(P−7)、式(P−11)、式(P−13)、式(P−15)又は式(P−18)が好ましく、式(P−1)、式(P−2)、式(P−3)、式(P−8)、式(P−11)又は式(P−13)がより好ましく、式(P−1)、式(P−2)又は式(P−3)がさらに好ましく、式(P−1)又は式(P−2)が特に好ましい。 In the general formula (I), P 1 and P 2 present represent a group selected from the formulas (P-1) to (P-20). P-1), Formula (P-2), Formula (P-3), Formula (P-4), Formula (P-5), Formula (P-7), Formula (P-11), Formula (P -13), formula (P-15) or formula (P-18) are preferred, and formula (P-1), formula (P-2), formula (P-3), formula (P-8), formula (P P-11) or formula (P-13) is more preferred, formula (P-1), formula (P-2) or formula (P-3) is more preferred, formula (P-1) or formula (P- 2) is particularly preferred.

一般式(I)において、RS1は基中の任意の水素原子がフッ素原子又は塩素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表す。原料の入手容易さ、合成の容易さ、液晶性、配向欠陥の少なさ及び光学特性の安定性の観点から、RS1は基中の任意の水素原子がフッ素原子又は塩素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−CO−、−COO−、−OCO−又は−O−CO−O−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すことが好ましく、RS1は基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−CO−、−COO−又は−OCO−によって置換されても良い炭素原子数1から10の直鎖状又は分岐状アルキル基を表すことがより好ましく、RS1は基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−によって置換されても良い炭素原子数1から10の直鎖状アルキル基を表すことがさらに好ましく、RS1は炭素原子数1から3の直鎖状アルキル基を表すことがさらにより好ましく、RS1はメチル基を表すことが特に好ましい。 In the general formula (I), R S1 may be any hydrogen atom in the group substituted by a fluorine atom or a chlorine atom, and one —CH 2 — or two or more —CH 2 — that are not adjacent to each other. Are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—. , —NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— Alternatively, it represents a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by -C≡C-. From the viewpoint of easy availability of raw materials, ease of synthesis, liquid crystallinity, a small number of alignment defects, and stability of optical properties, R S1 can be substituted with any hydrogen atom in the group by a fluorine atom or a chlorine atom. Well, one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —CO—, —COO—, —OCO— or —O—CO—O—. It preferably represents a linear or branched alkyl group having 1 to 20 carbon atoms that may be substituted by R 1 , and R S1 may be substituted with any hydrogen atom in the group by a fluorine atom. 1 to 10 carbon atoms in which —CH 2 — or two or more non-adjacent —CH 2 — may be each independently substituted by —O—, —CO—, —COO— or —OCO—. more preferably represents a linear or branched alkyl group, R S1 is Any hydrogen atom may be substituted by fluorine atoms in one -CH 2 - or nonadjacent two or more -CH 2 - may be replaced each by independently -O- is More preferably, it represents a linear alkyl group having 1 to 10 carbon atoms, R S1 more preferably represents a linear alkyl group having 1 to 3 carbon atoms, and R S1 represents a methyl group. Is particularly preferred.

一般式(I)において、Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良い。液晶性、原料の入手容易さ及び合成の容易さの観点から、Spは複数存在する場合は各々同一であっても異なっていても良く、炭素原子数2から12のアルキレン基を表すことが好ましく、炭素原子数2から10のアルキレン基を表すことがより好ましく、炭素原子数2から8のアルキレン基を表すことがさらに好ましく、炭素原子数2から6のアルキレン基を表すことがさらにより好ましく、炭素原子数2のアルキレン基を表すことが特に好ましい。 In the general formula (I), Sp 1 represents an alkylene group having 1 to 20 carbon atoms, and when a plurality of Sp 1 are present, they may be the same or different. From the viewpoint of liquid crystallinity, availability of raw materials, and ease of synthesis, when there are a plurality of Sp 1 s , they may be the same or different and each represents an alkylene group having 2 to 12 carbon atoms. Preferably, it represents an alkylene group having 2 to 10 carbon atoms, more preferably represents an alkylene group having 2 to 8 carbon atoms, and even more preferably represents an alkylene group having 2 to 6 carbon atoms. And particularly preferably an alkylene group having 2 carbon atoms.

一般式(I)において、Xは−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良い。原料の入手容易さ及び合成の容易さの観点から、Xは複数存在する場合は各々同一であっても異なっていても良く、−O−、−S−、−OCH−、−CHO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表すことが好ましく、−O−、−OCH−、−CHO−、−COO−、−OCO−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表すことがより好ましく、−O−、−COO−、−OCO−又は単結合を表すことがさらに好ましく、−O−又は単結合を表すことがさらにより好ましく、単結合を表すことが特に好ましい。 In the general formula (I), X 1 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO -, - O-CO- O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S- , -SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO- CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO —, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF—, —C≡C— or a single bond. But, they may be the same or different if X 1 is more present. From the viewpoint of availability of raw materials and ease of synthesis, when there are a plurality of X 1 s , they may be the same or different from each other, —O—, —S—, —OCH 2 —, —CH 2. O -, - COO -, - OCO -, - CO-S -, - S-CO -, - OCO-O -, - CO-NH -, - NH-CO -, - COO-CH 2 CH 2 —, —OCO—CH 2 CH 2 —, —CH 2 CH 2 —COO—, —CH 2 CH 2 —OCO— or a single bond is preferably represented, —O—, —OCH 2 —, —CH 2 O -, - COO -, - OCO -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - represents a CH 2 CH 2 -OCO- or a single bond And more preferably represents -O-, -COO-, -OCO- or a single bond. Preferably, the still more preferred that represents -O- or a single bond, and particularly preferably a single bond.

一般式(I)において、k1は0から10の整数を表すが、合成の容易さ及び液晶性の観点から、0から5の整数を表すことが好ましく、0から2の整数を表すことがより好ましく、0又は1を表すことがさらに好ましく、硬化収縮の少なさの観点から、1を表すことが特に好ましい。   In general formula (I), k1 represents an integer of 0 to 10, but preferably represents an integer of 0 to 5, and more preferably represents an integer of 0 to 2, from the viewpoint of ease of synthesis and liquid crystallinity. Preferably, 0 or 1 is more preferable, and 1 is particularly preferable from the viewpoint of low curing shrinkage.

一般式(I)において、n11及びn12は各々独立して0から8の整数を表すが、原料の入手容易さ、合成の容易さ、液晶性、配向欠陥の少なさ及び光学特性の安定性の観点から、各々独立して0から6の整数を表すことが好ましく、各々独立して0から4の整数を表すことがより好ましく、各々独立して0から2の整数を表すことがさらに好ましく、各々独立して0又は1を表すことが特に好ましい。また、重合性組成物に添加した際の保存安定性を重視する場合には、n11及びn12は各々異なる整数を表すことが好ましい。   In the general formula (I), n11 and n12 each independently represents an integer of 0 to 8, but the availability of raw materials, ease of synthesis, liquid crystallinity, few alignment defects, and stability of optical properties From the viewpoint, it is preferable that each independently represents an integer from 0 to 6, more preferably each independently represents an integer from 0 to 4, more preferably each independently represents an integer from 0 to 2, It is particularly preferred that each independently represents 0 or 1. Moreover, when importance is attached to the storage stability when added to the polymerizable composition, it is preferable that n11 and n12 each represent a different integer.

一般式(I)において、Rは水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、イソシアノ基、チオイソシアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、Rは下記の式(I−R2) In the general formula (I), R 2 is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, an isocyano group, a thioisocyano group, or an arbitrary group And a fluorine atom may be substituted with one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —OCH 2 —. , —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—, —NH—CO—. , —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH—OCO—, -COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 - , -OCO-CH 2 CH 2 - , - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - From 1 carbon atom which may be substituted by CH 2 —OCO—, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C—. 20 represents a linear or branched alkyl group, or R 2 represents the following formula (I-R2)

Figure 2018025752
Figure 2018025752

で表される基を表す。フィルムにした場合の柔軟性を重視する場合、Rは式(I−R2)で表される基以外の基を表すことが好ましく、フィルムにした場合の機械的強度を重視する場合、Rは式(I−R2)で表される基を表すことが好ましい。 Represents a group represented by In the case where importance is attached to the flexibility when made into a film, R 2 preferably represents a group other than the group represented by the formula (I-R2), and in the case where importance is given to the mechanical strength when made into a film, R 2 Preferably represents a group represented by the formula (I-R2).

が式(I−R2)で表される基以外の基を表す場合、液晶性及び合成の容易さの観点から、Rは水素原子、フッ素原子、塩素原子、シアノ基、若しくは、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−CO−、−COO−、−OCO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から12の直鎖又は分岐アルキル基を表すことが好ましく、Rは水素原子、フッ素原子、塩素原子、若しくは、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−CO−、−COO−、−OCO−又は−O−CO−O−によって置換されても良い炭素原子数1から12の直鎖又は分岐アルキル基を表すことがより好ましく、Rは水素原子、フッ素原子、塩素原子、若しくは、炭素原子数1から12の直鎖アルキル基又は直鎖アルコキシ基を表すことがさらに好ましく、Rは炭素原子数1から12の直鎖アルキル基又は直鎖アルコキシ基を表すことが特に好ましい。 When R 2 represents a group other than the group represented by formula (I-R2), R 2 represents a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, or 1 from the viewpoint of liquid crystallinity and ease of synthesis. number of -CH 2 - or nonadjacent two or more -CH 2 - are each independently -O -, - CO -, - COO -, - OCO -, - OCO-O -, - CO To represent a linear or branched alkyl group having 1 to 12 carbon atoms which may be substituted by —NH—, —NH—CO—, —CH═CH—, —CF═CF— or —C≡C—. Preferably, R 2 is a hydrogen atom, a fluorine atom, a chlorine atom, or one —CH 2 — or two or more non-adjacent —CH 2 —, each independently —O—, —CO—, — 1 to 12 carbon atoms which may be substituted by COO-, -OCO- or -O-CO-O- More preferably represents a straight-chain or branched alkyl group, R 2 represents a hydrogen atom, a fluorine atom, a chlorine atom, or, more preferably represent a straight chain alkyl group or straight chain alkoxy group having 1 to 12 carbon atoms, R 2 particularly preferably represents a linear alkyl group having 1 to 12 carbon atoms or a linear alkoxy group.

また、Rが式(I−R2)で表される基を表す場合、P、RS2、Sp、X、k2、n21及びn22の好ましい構造は、それぞれ、P、RS1、Sp、X、k1、n11及びn12の採用する好ましい構造と同様である。 When R 2 represents a group represented by the formula (I-R2), preferred structures of P 2 , R S2 , Sp 2 , X 2 , k 2 , n 21 and n 22 are P 1 , R S1 , sp 1, X 1, k1, is similar to the preferred structure employed in n11 and n12.

一般式(I)において、Mは下記の式(I−M1)で表される基を表す。 In the general formula (I), M 1 represents a group represented by the following formula (I-M1).

Figure 2018025752
Figure 2018025752

及びAは各々独立して1,4−フェニレン基、1,4−シクロヘキシレン基、ビシクロ[2.2.2]オクタン−1,4−ジイル基、ピリジン−2,5−ジイル基、ピリミジン−2,5−ジイル基、ナフタレン−2,6−ジイル基、ナフタレン−1,4−ジイル基、テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基又は1,3−ジオキサン−2,5−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良いが、Aが複数存在する場合それらは同一であっても異なっていても良い。合成の容易さ、原料の入手容易さ及び液晶性の観点から、A及びAは、各々独立して無置換であるか又は1つ以上の置換基Lによって置換されても良い1,4−フェニレン基、1,4−シクロヘキシレン基、ビシクロ[2.2.2]オクタン−1,4−ジイル基、ナフタレン−2,6−ジイル基を表すことがより好ましく、各々独立して下記の式(A−1)から式(A−13) A 1 and A 2 are each independently 1,4-phenylene group, 1,4-cyclohexylene group, bicyclo [2.2.2] octane-1,4-diyl group, pyridine-2,5-diyl group. , Pyrimidine-2,5-diyl group, naphthalene-2,6-diyl group, naphthalene-1,4-diyl group, tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group or 1 , 3-dioxane-2,5-diyl groups, these groups may be unsubstituted or substituted by one or more substituents L, but they are the same when there are multiple A 1 Or different. In view of ease of synthesis, availability of raw materials, and liquid crystallinity, A 1 and A 2 are each independently unsubstituted or may be substituted with one or more substituents L -Preferably represents a phenylene group, 1,4-cyclohexylene group, bicyclo [2.2.2] octane-1,4-diyl group, naphthalene-2,6-diyl group, each independently Formula (A-1) to Formula (A-13)

Figure 2018025752
Figure 2018025752

から選ばれる基を表すことがさらに好ましく、さらに屈折率異方性の低さを重視する場合は、各々独立して式(A−1)から式(A−8)、式(A−13)から選ばれる基を表すことがさらにより好ましく、各々独立して式(A−1)から式(A−5)、式(A−13)から選ばれる基を表すことがさらにより好ましく、各々独立して式(A−1)から式(A−4)、式(A−13)から選ばれる基を表すことがさらにより好ましく、各々独立して式(A−1)、式(A−2)又は式(A−13)から選ばれる基を表すことが特に好ましい。
Lはフッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、ニトロ基、シアノ基、イソシアノ基、アミノ基、ヒドロキシル基、メルカプト基、メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基、ジイソプロピルアミノ基、トリメチルシリル基、ジメチルシリル基、チオイソシアノ基、又は、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子に置換されても良く、若しくは、Lは下記の式(I−RL)
It is further preferable to represent a group selected from the group consisting of: (1) to (A-8) and (A-13) independently when the importance of low refractive index anisotropy is emphasized. It is even more preferable to represent a group selected from the formula (A-1) to the formula (A-5), and it is even more preferable to represent a group selected from the formula (A-13). It is even more preferable to represent a group selected from Formula (A-1) to Formula (A-4) and Formula (A-13), and each independently represents Formula (A-1) and Formula (A-2). ) Or a group selected from formula (A-13).
L is fluorine atom, chlorine atom, bromine atom, iodine atom, pentafluorosulfuranyl group, nitro group, cyano group, isocyano group, amino group, hydroxyl group, mercapto group, methylamino group, dimethylamino group, diethylamino group, A diisopropylamino group, a trimethylsilyl group, a dimethylsilyl group, a thioisocyano group, or one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, — CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO- , —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF—, or carbon atom optionally substituted by —C≡C— Number 1 20 represents a linear or branched alkyl group, and any hydrogen atom in the alkyl group may be substituted with a fluorine atom, or L represents the following formula (I-RL):

Figure 2018025752
Figure 2018025752

で表される基を表すが、化合物内にLが複数存在する場合それらは同一であっても異なっていても良い。液晶性、合成の容易さの観点から、置換基Lはフッ素原子、塩素原子、ペンタフルオロスルフラニル基、ニトロ基、メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基、ジイソプロピルアミノ基、又は、任意の水素原子はフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−は各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−O−CO−O−、−CH=CH−、−CF=CF−又は−C≡C−から選択される基によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すことが好ましく、置換基Lはフッ素原子、塩素原子、又は、任意の水素原子はフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−は各々独立して−O−、−COO−又は−OCO−から選択される基によって置換されても良い炭素原子数1から12の直鎖状又は分岐状アルキル基を表すことがより好ましく、置換基Lはフッ素原子、塩素原子、又は、任意の水素原子はフッ素原子に置換されても良い炭素原子数1から12の直鎖状又は分岐状アルキル基若しくはアルコキシ基を表すことがさらに好ましく、置換基Lはフッ素原子、塩素原子、又は、炭素原子数1から8の直鎖アルキル基若しくは直鎖アルコキシ基を表すことがさらにより好ましく、置換基Lはフッ素原子、塩素原子、又は、メチル基又はメトキシ基を表すことが特に好ましい。また、Lが式(I−RL)で表される基を表す場合、P、RSL、Sp、X、kL、nL1及びnL2の好ましい構造は、それぞれ、P、RS1、Sp、X、k1、n11及びn12の採用する好ましい構造と同様である。
は−O−、−S−、−OCH−、−CHO−、−CHCH−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−OCO−NH−、−NH−COO−、−NH−CO−NH−、−NH−O−、−O−NH−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−、−N=CH−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Zが複数存在する場合それらは同一であっても異なっていても良い。液晶性、原料の入手容易さ及び合成の容易さの観点から、Z及びZは各々独立して−OCH−、−CHO−、−COO−、−OCO−、−CFO−、−OCF−、−CHCH−、−CFCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−CH=CH−、−CF=CF−、−C≡C−又は単結合を表すことが好ましく、−OCH−、−CHO−、−COO−、−OCO−、−CFO−、−OCF−、−CHCH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−CH=CH−、−C≡C−又は単結合を表すことがより好ましく、−OCH−、−CHO−、−COO−、−OCO−、−CFO−、−OCF−又は単結合を表すことがさらに好ましく、−OCH−、−CHO−、−COO−、−OCO−又は単結合を表すことがさらにより好ましく、−COO−又は−OCO−を表すことが特に好ましい。
m1は0から5の整数を表すが、溶媒への溶解性及び液晶性の観点から、0から4の整数を表すことが好ましく、1から4の整数を表すことがより好ましく、1、2又は4を表すことがさらに好ましく、2又は4を表すことが特に好ましい。
In the case where a plurality of L are present in the compound, they may be the same or different. From the viewpoint of liquid crystallinity and ease of synthesis, the substituent L is a fluorine atom, chlorine atom, pentafluorosulfuranyl group, nitro group, methylamino group, dimethylamino group, diethylamino group, diisopropylamino group, or any A hydrogen atom may be substituted with a fluorine atom, and one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, — 1 to 20 carbon atoms which may be substituted by a group selected from COO—, —OCO—, —O—CO—O—, —CH═CH—, —CF═CF— or —C≡C—. It is preferable to represent a linear or branched alkyl group, and the substituent L may be a fluorine atom, a chlorine atom, or an arbitrary hydrogen atom may be substituted with a fluorine atom, and one —CH 2 — or adjacent group may be substituted. not two or more -CH 2 - More preferably, each independently represents a linear or branched alkyl group having 1 to 12 carbon atoms which may be substituted with a group selected from —O—, —COO— or —OCO—. More preferably, L represents a fluorine atom, a chlorine atom, or an arbitrary hydrogen atom, a linear or branched alkyl group or alkoxy group having 1 to 12 carbon atoms, which may be substituted with a fluorine atom. More preferably, L represents a fluorine atom, a chlorine atom, or a linear alkyl group or linear alkoxy group having 1 to 8 carbon atoms, and the substituent L is a fluorine atom, a chlorine atom, a methyl group or a methoxy group. It is particularly preferred to represent a group. When L represents a group represented by the formula (I-RL), preferred structures of P L , R SL , Sp L , X L , kL, nL 1 and nL 2 are P 1 , R S1 , Sp respectively. 1 , X 1 , k1, n11 and n12 are the same as the preferred structures adopted.
Z 1 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -OCO-NH-, -NH-COO-, -NH-CO-NH-, -NH-O-,- O—NH—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH -OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH CH -, - N = N -, - CH = N -, - N = CH -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, Z When a plurality of 1 are present, they may be the same or different. Z 1 and Z 2 are each independently —OCH 2 —, —CH 2 O—, —COO—, —OCO—, —CF 2 O from the viewpoint of liquid crystallinity, availability of raw materials, and ease of synthesis. -, - OCF 2 -, - CH 2 CH 2 -, - CF 2 CF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - CH = CH -, - CF = CF- , —C≡C— or a single bond is preferred, —OCH 2 —, —CH 2 O—, —COO—, —OCO—, —CF 2 O—, —OCF 2 —, —CH 2 CH 2 -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 C 2 -COO -, - CH 2 CH 2 -OCO -, - CH = CH -, - C≡C- or is more preferably a single bond, -OCH 2 -, - CH 2 O -, - COO-, More preferably, it represents —OCO—, —CF 2 O—, —OCF 2 — or a single bond, and further represents —OCH 2 —, —CH 2 O—, —COO—, —OCO— or a single bond. More preferably, it represents -COO- or -OCO-.
m1 represents an integer of 0 to 5, but from the viewpoint of solubility in a solvent and liquid crystallinity, it preferably represents an integer of 0 to 4, more preferably an integer of 1 to 4, 4 is more preferable, and 2 or 4 is particularly preferable.

一般式(I)で表される化合物はキラル化合物であってもよい。その場合、下記の一般式(I−C)   The compound represented by the general formula (I) may be a chiral compound. In that case, the following general formula (IC)

Figure 2018025752
Figure 2018025752

(式中、P、RS1、Sp、X、k1、n11、n12及びMは各々一般式(I)におけるP、RS1、Sp、X、k1、n11、n12及びMと同じ意味を表し、Cは不斉炭素原子を表し、R2Cは水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、イソシアノ基、チオイソシアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、R2Cは下記の式(I−R2−C) (Wherein, P 1, R S1, Sp 1, X 1, k1, n11, n12 and M 1 are each P 1, R S1 in the general formula (I), Sp 1, X 1, k1, n11, n12 and M 1 represents the same meaning, * C represents an asymmetric carbon atom, R 2C represents a hydrogen atom, fluorine atom, chlorine atom, bromine atom, iodine atom, pentafluorosulfuranyl group, cyano group, nitro group, isocyano Group, thioisocyano group, or any hydrogen atom in the group may be substituted with a fluorine atom, and one —CH 2 — or two or more non-adjacent —CH 2 — are each independently — O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, -CO-NH -, - NH- CO -, - SCH 2 -, - CH 2 S-, CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 —, —CH 2 —COO—, —CH 2 —OCO—, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C—. Represents a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by R 2C , or R 2C is represented by the following formula (I-R2-C):

Figure 2018025752
Figure 2018025752

(式中、P、RS2、Sp、X、k2、n21及びn22は各々一般式(I)におけるP、RS2、Sp、X、k2、n21及びn22と同じ意味を表し、Cは不斉炭素原子を表す。)で表される化合物が好ましい。各基の好ましい構造は上記と同様である。 (In the formula, P 2 , R S2 , Sp 2 , X 2 , k 2 , n 21 and n 22 have the same meanings as P 2 , R S 2 , Sp 2 , X 2 , X 2 , k 2 , n 21 and n 22 in the general formula (I), respectively. And a compound represented by * C represents an asymmetric carbon atom) is preferable. The preferred structure of each group is the same as described above.

一般式(I)で表される化合物としては、下記の一般式(I−A)   As a compound represented by general formula (I), the following general formula (IA)

Figure 2018025752
Figure 2018025752

(式中、P及びMは各々一般式(I)におけるP及びMと同じ意味を表し、Sp11及びX11は各々一般式(I)におけるSp及びXと同じ意味を表し、n111及びn121は各々独立して0又は1を表すが、n111+n121は1を表し、R21は下記の式(I−R2−A) (In the formula, P 1 and M 1 each have the same meaning as P 1 and M 1 in the general formula (I), and Sp 11 and X 11 each have the same meaning as Sp 1 and X 1 in the general formula (I). represents, n111 and n121 represents 0 or 1 each independently is, n111 + n121 represents 1, R 21 is the following formula (I-R2-a)

Figure 2018025752
Figure 2018025752

(式中、Pは一般式(I)におけるPと同じ意味を表し、Sp21及びX21は各々一般式(I)におけるSp及びXと同じ意味を表し、n211及びn221は各々独立して0又は1を表すが、n211+n221は1を表す。)で表される基を表す。)で表される化合物であることが好ましい。重合性組成物に添加した際の保存安定性を特に重視する場合、一般式(I−A)において、n111が0を表し、n121が1を表し、R21が式(I−R2−A)で表される基を表し、n211が1を表し、n221が0を表すことが好ましい。また、合成の容易さ及び原料の入手容易さを重視する場合、一般式(I)で表される化合物としては、下記の一般式(I−A−11) (Wherein, P 2 has the same meaning as P 2 in formula (I), Sp 21 and X 21 are as defined Sp 2 and X 2 each in the general formula (I), each n211 and n221 Independently represents 0 or 1, but n211 + n221 represents 1.). It is preferable that it is a compound represented by this. Especially when emphasis on storage stability when added to the polymerizable composition, in the general formula (I-A), n111 represents 0, n121 represents 1, R 21 has the formula (I-R2-A) It is preferable that n211 represents 1 and n221 represents 0. In the case where importance is attached to the ease of synthesis and the availability of raw materials, the compound represented by the general formula (I) is represented by the following general formula (IA-11).

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−22) (In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), Sp 11 , Sp 21 , X 11 , X 21 and M 1 represent the same meaning) and the following general formula (IA-22)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−12) (In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), Sp 11 , Sp 21 , X 11 , X 21 and M 1 represent the same meanings) and the following general formula (IA-12)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−21) (In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), Sp 11 , Sp 21 , X 11 , X 21 and M 1 represent the same meanings) and the following general formula (IA-21)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物との混合物であることが好ましく、下記の一般式(I−A−111) (In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), It is preferably a mixture with a compound represented by Sp 11 , Sp 21 , X 11 , X 21 and M 1 ), and represented by the following general formula (IA-111)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12及びA21は各々独立して1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z11及びZ12は各々独立して−OCH−、−CHO−、−CHCH−、−COO−、−OCO−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表す。)で表される化合物と、下記の一般式(I−A−221) (Wherein, P 1 and P 2 each represent a formula (I-A) or the same meaning as P 1 and P 2 in the general formula (I-R2-A), A 11, A 12 and A 21 are each Independently represents a 1,4-phenylene group or a 1,4-cyclohexylene group, these groups may be unsubstituted or substituted by one or more substituents L, Z 11 and Z 12 Each independently represents —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —COO—, —OCO—, —CO—NH—, —NH—CO—, —CH═CH—COO—. , —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, —CH 2 CH 2 —COO -, -. CH 2 CH 2 -OCO- or a single bond) the compound represented by And the following general formula (IA-221)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−121) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 each represent the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 in general formula (IA-111), and the following general formula (I -A-121)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−211) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 each represent the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 in general formula (IA-111), and the following general formula (I -A-211)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物との混合物若しくは下記の一般式(I−A−112) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 represent the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 in the general formula (IA-111), respectively) or a mixture represented by the following general formula (IA-112)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14及びA21は各々独立して1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z11、Z12、Z13及びZ14は各々独立して−OCH−、−CHO−、−CHCH−、−COO−、−OCO−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表す。)で表される化合物と、下記の一般式(I−A−222) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 and A 21 each independently represents a 1,4-phenylene group or a 1,4-cyclohexylene group, but these groups may be unsubstituted or substituted by one or more substituents L. , Z 11 , Z 12 , Z 13 and Z 14 are each independently —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —COO—, —OCO—, —CO—NH—, — NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO Or a single bond. A compound represented by), the general formula (I-A-222)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−122) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). represents the same meaning as 13 and Z 14. a compound represented by), the general formula (I-a-122)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−212) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). 13 and Z 14 have the same meaning.) And the following general formula (IA-212)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物との混合物であることがより好ましく、下記の一般式(I−A−1111) (In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). more preferably is a mixture of a compound represented by the representative.) the same meaning as 13 and Z 14, the following general formula (I-a-1111)

Figure 2018025752
Figure 2018025752

(式中、W及びWは各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、A121は1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z111及びZ121は各々独立して−OCH−、−CHO−、−COO−又は−OCO−を表す。)で表される化合物と、下記の一般式(I−A−2211) Wherein W 1 and W 2 each independently represent a hydrogen atom, a methyl group, a trifluoromethyl group or a fluorine atom, and A 121 represents a 1,4-phenylene group or a 1,4-cyclohexylene group. , These groups may be unsubstituted or substituted by one or more substituents L, and Z 111 and Z 121 are each independently —OCH 2 —, —CH 2 O—, —COO— or -OCO-) and the following general formula (IA-2211)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、Z111及びZ121は各々一般式(I−A−1111)におけるW、W、A121、Z111及びZ121と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−1211) (The same meaning as W 1, W 2, A 121 , Z 111 and Z 121 in the formula, W 1, W 2, A 121, Z 111 and Z 121 are each formula (I-A-1111). And a compound represented by the following general formula (IA-1211)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、Z111及びZ121は各々一般式(I−A−1111)におけるW、W、A121、Z111及びZ121と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−2111) (The same meaning as W 1, W 2, A 121 , Z 111 and Z 121 in the formula, W 1, W 2, A 121, Z 111 and Z 121 are each formula (I-A-1111). ) And the following general formula (IA-2111)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、Z111及びZ121は各々一般式(I−A−1111)におけるW、W、A121、Z111及びZ121と同じ意味を表す。)で表される化合物との混合物若しくは下記の一般式(I−A−1121) (The same meaning as W 1, W 2, A 121 , Z 111 and Z 121 in the formula, W 1, W 2, A 121, Z 111 and Z 121 are each formula (I-A-1111). ) Or a compound represented by the following general formula (IA-1121)

Figure 2018025752
Figure 2018025752

(式中、W及びWは各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、A121及びA141は1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z111、Z121、Z131及びZ141は各々独立して−OCH−、−CHO−、−COO−又は−OCO−を表し、Lはフッ素原子、塩素原子、又は、炭素原子数1から8の直鎖アルキル基若しくは直鎖アルコキシ基を表す。)で表される化合物と、下記の一般式(I−A−2221) Wherein W 1 and W 2 each independently represent a hydrogen atom, a methyl group, a trifluoromethyl group or a fluorine atom, and A 121 and A 141 each represent a 1,4-phenylene group or a 1,4-cyclohexylene group. Wherein these groups may be unsubstituted or substituted by one or more substituents L, and Z 111 , Z 121 , Z 131 and Z 141 are each independently —OCH 2 —, — CH 2 O—, —COO— or —OCO— is represented, and L 1 represents a fluorine atom, a chlorine atom, or a linear alkyl group or linear alkoxy group having 1 to 8 carbon atoms. Compound with the following general formula (IA-2221)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、A141、Z111、Z121、Z131、Z141及びLは各々一般式(I−A−1121)におけるW、W、A121、A141、Z111、Z121、Z131、Z141及びLと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−1221) Wherein W 1 , W 2 , A 121 , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 are W 1 , W 2 , A 121 in the general formula (IA-1121), respectively. , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 ), and the following general formula (IA-1221)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、A141、Z111、Z121、Z131、Z141及びLは各々一般式(I−A−1121)におけるW、W、A121、A141、Z111、Z121、Z131、Z141及びLと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−2121) Wherein W 1 , W 2 , A 121 , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 are W 1 , W 2 , A 121 in the general formula (IA-1121), respectively. , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 have the same meanings) and the following general formula (IA-2121)

Figure 2018025752
Figure 2018025752

(式中、W、W、A121、A141、Z111、Z121、Z131、Z141及びLは各々一般式(I−A−1121)におけるW、W、A121、A141、Z111、Z121、Z131、Z141及びLと同じ意味を表す。)で表される化合物との混合物であることがさらに好ましく、下記の一般式(I−A−11111) Wherein W 1 , W 2 , A 121 , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 are W 1 , W 2 , A 121 in the general formula (IA-1121), respectively. , A 141 , Z 111 , Z 121 , Z 131 , Z 141, and L 1 are more preferably a mixture with a compound represented by the following general formula (IA-11111): )

Figure 2018025752
Figure 2018025752

(式中、W11及びW21は各々独立して水素原子又はメチル基を表す。)で表される化合物と、下記の一般式(I−A−22111) (Wherein W 11 and W 21 each independently represents a hydrogen atom or a methyl group) and the following general formula (IA-22111)

Figure 2018025752
Figure 2018025752

(式中、W11及びW21は各々一般式(I−A−11111)におけるW11及びW21と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−12111) (Wherein W 11 and W 21 each represent the same meaning as W 11 and W 21 in formula (IA-11111)), and the following formula (IA-12111) )

Figure 2018025752
Figure 2018025752

(式中、W11及びW21は各々一般式(I−A−1111)におけるW11及びW21と同じ意味を表す。)で表される化合物との混合物若しくは下記の一般式(I−A−11211) (Wherein W 11 and W 21 each represent the same meaning as W 11 and W 21 in formula (IA-1111)), or a mixture with a compound represented by the following formula (IA -11211)

Figure 2018025752
Figure 2018025752

(式中、W11及びW21は各々独立して水素原子又はメチル基を表し、L11はフッ素原子、塩素原子、又は、メチル基又はメトキシ基を表す。)で表される化合物と、下記の一般式(I−A−22211) (Wherein W 11 and W 21 each independently represent a hydrogen atom or a methyl group, and L 11 represents a fluorine atom, a chlorine atom, or a methyl group or a methoxy group) and the following: General formula (IA-22221)

Figure 2018025752
Figure 2018025752

(式中、W11、W21及びL11は各々一般式(I−A−11211)におけるW11、W21及びL11と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−12211) (Wherein W 11 , W 21 and L 11 represent the same meanings as W 11 , W 21 and L 11 in general formula (IA-11211), respectively), and the following general formula (IA-12111)

Figure 2018025752
Figure 2018025752

(式中、W11、W21及びL11は各々一般式(I−A−11211)におけるW11、W21及びL11と同じ意味を表す。)で表される化合物と、下記の一般式(I−A−21211) (Wherein W 11 , W 21 and L 11 represent the same meanings as W 11 , W 21 and L 11 in general formula (IA-11211), respectively), and the following general formula (IA-21211)

Figure 2018025752
Figure 2018025752

(式中、W11、W21及びL11は各々一般式(I−A−11211)におけるW11、W21及びL11と同じ意味を表す。)で表される化合物との混合物であることが特に好ましい。 It is a mixture of (wherein, W 11, W 21 and L 11 are each general formula (. Represents the same meaning as W 11, W 21 and L 11 in the I-A-11211)) a compound represented by Is particularly preferred.

また、液晶性の観点から、一般式(I)で表される化合物に含まれる1,4−シクロヘキシレン基、1,3−ジオキサン−2,5−ジイル基及びデカヒドロナフタレン−2,6−ジイル基はシス体及びトランス体のいずれか一方のみであっても、両方の混合物であっても良いが、液晶性の観点からトランス体が主成分であることが好ましく、トランス体のみであることが特に好ましい。以下の化合物においても同様である。   Further, from the viewpoint of liquid crystallinity, 1,4-cyclohexylene group, 1,3-dioxane-2,5-diyl group and decahydronaphthalene-2,6-included in the compound represented by the general formula (I) The diyl group may be either a cis isomer or a trans isomer, or a mixture of both, but from the viewpoint of liquid crystallinity, the trans isomer is preferably the main component, and only the trans isomer. Is particularly preferred. The same applies to the following compounds.

本願発明の光学フィルムは、ネマチック相、スメクチック相、キラルスメクチック相又はコレステリック相構造を有することが好ましく、キラルスメクチック相又はコレステリック相構造を有することがより好ましく、コレステリック相構造を有することが特に好ましい。   The optical film of the present invention preferably has a nematic phase, a smectic phase, a chiral smectic phase, or a cholesteric phase structure, more preferably has a chiral smectic phase or a cholesteric phase structure, and particularly preferably has a cholesteric phase structure.

上記一般式(I)で表される化合物は1種又は2種以上用いても良いが、光学フィルムを製造する際に使用する当該重合性化合物の合計含有量は、光学フィルムを製造する際に使用する重合性化合物の合計量のうち、1〜99質量%含有することが好ましく、10〜90質量%含有することがより好ましく、20〜80質量%含有することが特に好ましい。得られる光学フィルムの配向性を重視する場合には上限値を80質量%以下とすることが好ましく、70質量%以下とすることがより好ましく、60質量%以下とすることが特に好ましい。また、液晶組成物の保存安定性を重視する場合には下限値を20質量%以上とすることが好ましく、30質量%以上とすることがより好ましく、40質量%以上とすることが特に好ましい。また、一般式(I)で表される化合物がキラル化合物である場合、光学フィルムを製造する際に使用する一般式(I)で表されるキラル化合物の合計含有量は、光学フィルムを製造する際に使用する重合性化合物の合計量のうち、0.1〜80質量%含有することが好ましく、1〜70質量%含有することがより好ましく、5〜50質量%含有することが特に好ましい。   Although the compound represented by the said general formula (I) may be used 1 type, or 2 or more types, when manufacturing an optical film, the total content of the said polymeric compound used when manufacturing an optical film is used. It is preferable to contain 1-99 mass% among the total amount of the polymeric compound to be used, it is more preferable to contain 10-90 mass%, and it is especially preferable to contain 20-80 mass%. When placing importance on the orientation of the obtained optical film, the upper limit is preferably 80% by mass or less, more preferably 70% by mass or less, and particularly preferably 60% by mass or less. Moreover, when importance is attached to the storage stability of the liquid crystal composition, the lower limit is preferably 20% by mass or more, more preferably 30% by mass or more, and particularly preferably 40% by mass or more. In addition, when the compound represented by the general formula (I) is a chiral compound, the total content of the chiral compound represented by the general formula (I) used in producing the optical film is the same as that for producing the optical film. Of the total amount of the polymerizable compounds used in this case, the content is preferably 0.1 to 80% by mass, more preferably 1 to 70% by mass, and particularly preferably 5 to 50% by mass.

本願発明の光学フィルムの材料として、一般式(I)で表される化合物以外に他の化合物を添加しても構わない。一般式(I)で表される化合物と混合して使用される他の重合性化合物としては、下記の一般式(II)   In addition to the compound represented by the general formula (I), other compounds may be added as the material for the optical film of the present invention. Other polymerizable compounds used by mixing with the compound represented by the general formula (I) include the following general formula (II)

Figure 2018025752
Figure 2018025752

(式中、P及びPは各々独立してラジカル重合、カチオン重合又はアニオン重合によって重合する基を表し、
Sp及びSpは各々独立してスペーサー基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、Spが複数存在する場合それらは同一であっても異なっていても良く、
及びXは各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、Xが複数存在する場合それらは同一であっても異なっていても良く、
k3及びk4は各々独立して0から10の整数を表し、
及びAは各々独立して1,4−フェニレン基、1,4−シクロヘキシレン基、ビシクロ[2.2.2]オクタン−1,4−ジイル基、ピリジン−2,5−ジイル基、ピリミジン−2,5−ジイル基、ナフタレン−2,6−ジイル基、ナフタレン−1,4−ジイル基、テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基又は1,3−ジオキサン−2,5−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良いが、Aが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CHCH−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−OCO−NH−、−NH−COO−、−NH−CO−NH−、−NH−O−、−O−NH−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−、−N=CH−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Zが複数存在する場合それらは同一であっても異なっていても良く、
m2は0から5の整数を表す。)で表される化合物が好ましい。ただし、一般式(II)で表される化合物には一般式(I)で表される化合物を含まない。
(Wherein P 3 and P 4 each independently represent a group that is polymerized by radical polymerization, cationic polymerization, or anionic polymerization;
Sp 3 and Sp 4 each independently represent a spacer group. When a plurality of Sp 3 are present, they may be the same or different, and when a plurality of Sp 4 are present, they may be the same. May be different,
X 3 and X 4 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO -, - O-CO- O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S- , -SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO- CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO —, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF—, —C≡C— or a single bond. But they if X 3 there are a plurality may be the same or different and they if X 4 there are a plurality may be the same or different and
k3 and k4 each independently represents an integer of 0 to 10,
A 3 and A 4 are each independently 1,4-phenylene group, 1,4-cyclohexylene group, bicyclo [2.2.2] octane-1,4-diyl group, pyridine-2,5-diyl group. , Pyrimidine-2,5-diyl group, naphthalene-2,6-diyl group, naphthalene-1,4-diyl group, tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group or 1 , 3-dioxane-2,5-diyl groups, these groups may be unsubstituted or substituted by one or more substituents L, but they are the same when there are multiple A 3 Can be different,
Z 2 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -OCO-NH-, -NH-COO-, -NH-CO-NH-, -NH-O-,- O—NH—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH -OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH CH -, - N = N -, - CH = N -, - N = CH -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, Z When two or more 2 exist, they may be the same or different,
m2 represents an integer of 0 to 5. ) Is preferred. However, the compound represented by the general formula (II) does not include the compound represented by the general formula (I).

一般式(II)において、P及びPは各々独立してラジカル重合、カチオン重合又はアニオン重合により重合する基を表すが、各々独立して上記の式(P−1)から式(P−20)から選ばれる基を表すことが好ましい。特に重合方法として紫外線重合を行う場合には、式(P−1)、式(P−2)、式(P−3)、式(P−4)、式(P−5)、式(P−7)、式(P−11)、式(P−13)、式(P−15)又は式(P−18)が好ましく、式(P−1)、式(P−2)、式(P−3)、式(P−8)、式(P−11)又は式(P−13)がより好ましく、式(P−1)、式(P−2)又は式(P−3)がさらに好ましく、式(P−1)又は式(P−2)が特に好ましい。 In the general formula (II), P 3 and P 4 each independently represent a group that is polymerized by radical polymerization, cationic polymerization, or anionic polymerization, and each independently represents the above formula (P-1) to formula (P- It is preferable to represent a group selected from 20). In particular, when ultraviolet polymerization is performed as a polymerization method, the formula (P-1), formula (P-2), formula (P-3), formula (P-4), formula (P-5), formula (P -7), formula (P-11), formula (P-13), formula (P-15) or formula (P-18) are preferred, and formula (P-1), formula (P-2), formula (P-18) P-3), formula (P-8), formula (P-11) or formula (P-13) is more preferred, and formula (P-1), formula (P-2) or formula (P-3) is more preferred. More preferred is formula (P-1) or (P-2).

一般式(II)において、Sp及びSpはそれぞれ独立してスペーサー基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、Spが複数存在する場合それらは同一であっても異なっていても良く、液晶性、原料の入手容易さ及び合成の容易さの観点から、Sp及びSpは複数存在する場合は各々同一であっても異なっていても良く、各々独立して1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−に置き換えられても良い炭素原子数1から20のアルキレン基を表すことが好ましく、Sp及びSpは複数存在する場合は各々同一であっても異なっていても良く、各々独立して1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−、−OCO−、−OCO−O−、−CO−NH−、−NH−CO−、−CH=CH−又は−C≡C−に置き換えられても良い炭素原子数1から20のアルキレン基を表すことがより好ましく、Sp及びSpは複数存在する場合は各々同一であっても異なっていても良く、各々独立して1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−、−OCO−又は−OCO−O−に置き換えられても良い炭素原子数1から20の直鎖状アルキレン基を表すことがさらに好ましく、Sp及びSpは複数存在する場合は各々同一であっても異なっていても良く、各々独立して1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−に置き換えられても良い炭素原子数1から12の直鎖状アルキレン基を表すことがさらにより好ましく、Sp及びSpは複数存在する場合は各々同一であっても異なっていても良く、各々独立して炭素原子数1から12の直鎖状アルキレン基を表すことが特に好ましい。 In the general formula (II), Sp 3 and Sp 4 each independently represent a spacer group. When a plurality of Sp 3 are present, they may be the same or different, and when a plurality of Sp 4 are present. They may be the same or different. From the viewpoint of liquid crystallinity, availability of raw materials, and ease of synthesis, Sp 3 and Sp 4 may be the same or different when there are a plurality of them. Each independently of one —CH 2 — or two or more non-adjacent —CH 2 — may be independently —O—, —S—, —OCH 2 —, —CH 2 O—. , —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—, —NH—CO—, —SCH 2 —, -CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SC 2 -, - CH = CH- COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - Represents an alkylene group having 1 to 20 carbon atoms which may be replaced by CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C—. In the case where a plurality of Sp 3 and Sp 4 are present, they may be the same or different, and each independently represents one —CH 2 — or two or more —CH 2 — that are not adjacent to each other. Are each independently -O-, -COO-, -OCO-, -OCO-O- , —CO—NH—, —NH—CO—, —CH═CH— or —C≡C—, more preferably represents an alkylene group having 1 to 20 carbon atoms which may be replaced by Sp 3 and Sp. 4 may be the same or different when there are a plurality of 4 and each independently represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O More preferably, it represents a linear alkylene group having 1 to 20 carbon atoms which may be replaced by-, -COO-, -OCO- or -OCO-O-, and when there are a plurality of Sp 3 and Sp 4 Each may be the same or different, and may each independently represent one —CH 2 — or two or more non-adjacent —CH 2 — each independently replaced by —O—. Good linear alkylene group having 1 to 12 carbon atoms Even more preferably it represents, Sp 3 and Sp 4 may be different even each identical in the presence of two or more, may represent a linear alkylene group having 1 to 12 carbon atoms each independently Particularly preferred.

一般式(II)において、X及びXは各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、Xが複数存在する場合それらは同一であっても異なっていても良い。原料の入手容易さ及び合成の容易さの観点から、X及びXは複数存在する場合は各々同一であっても異なっていても良く、各々独立して−O−、−S−、−OCH−、−CHO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表すことが好ましく、各々独立して−O−、−OCH−、−CHO−、−COO−、−OCO−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表すことがより好ましく、各々独立して−O−、−COO−、−OCO−又は単結合を表すことがさらに好ましく、各々独立して−O−又は単結合を表すことがさらにより好ましく、それぞれ−O−を表すことが特に好ましい。 In the general formula (II), X 3 and X 4 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO. -S -, - S-CO - , - O-CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH -, - N = N -, - CH = N-N = CH -, - CF = CF-, C≡C- or represents a single bond, they if X 3 there are a plurality may be different even in the same, X 4 may be those when the plurality of different may be the same . From the viewpoint of easy availability of raw materials and ease of synthesis, when there are a plurality of X 3 and X 4, they may be the same or different and each independently represents —O—, —S—, — OCH 2 -, - CH 2 O -, - COO -, - OCO -, - CO-S -, - S-CO -, - OCO-O -, - CO-NH -, - NH-CO-, -COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - it is preferable to represent a CH 2 CH 2 -OCO- or a single bond, each independently -O -, - OCH 2 -, - CH 2 O -, - COO -, - OCO -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH more preferably represents an 2 CH 2 -OCO- or a single bond, each independently -O -, - OO -, - OCO- or more preferably a single bond, even more preferably represent each independently -O- or a single bond, and particularly preferably each represent -O-.

一般式(II)において、k3及びk4は各々独立して0から10の整数を表すが、合成の容易さ及び液晶性の観点から、各々独立して0から5の整数を表すことが好ましく、各々独立して0から2の整数を表すことがより好ましく、各々独立して0又は1を表すことがさらに好ましく、フィルムにした場合の硬化収縮の少なさの観点から、各々1を表すことが特に好ましい。   In general formula (II), k3 and k4 each independently represent an integer of 0 to 10, but from the viewpoint of ease of synthesis and liquid crystallinity, it is preferable that each independently represents an integer of 0 to 5, More preferably, each independently represents an integer of 0 to 2, more preferably each independently represents 0 or 1, and each represents 1 from the viewpoint of low curing shrinkage when formed into a film. Particularly preferred.

ただし、一般式(II)において、P−(Sp−Xk3−及び−(X−Spk4−Pには−O−O−結合を含まない。 However, in the general formula (II), P 3 - ( Sp 3 -X 3) k3 - and - (X 4 -Sp 4) k4 in -P 4 does not contain -O-O- bond.

一般式(II)において、A、A、Z及びm2の好ましい構造は、それぞれ、一般式(I)におけるA、A、Z及びm1の採用する好ましい構造と同様である。また、Lの好ましい構造は上記と同様である。 In the general formula (II), preferred structures of A 3 , A 4 , Z 2 and m 2 are the same as the preferred structures adopted by A 1 , A 2 , Z 1 and m 1 in the general formula (I), respectively. The preferred structure for L is the same as described above.

一般式(II)で表される化合物としては、下記の一般式(II−A)   As a compound represented by general formula (II), the following general formula (II-A)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp、Sp、X、X、k3及びk4は各々一般式(II)におけるP、P、Sp、Sp、X、X、k3及びk4と同じ意味を表し、A31、A32及びA41は各々独立して1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z21及びZ22は各々独立して−OCH−、−CHO−、−CHCH−、−COO−、−OCO−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表す。)で表される化合物が好ましく、下記の一般式(II−A−1) (In the formula, P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 , k 3 and k 4 are respectively P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 in the general formula (II)). , K3 and k4 have the same meanings, and A 31 , A 32 and A 41 each independently represent a 1,4-phenylene group or a 1,4-cyclohexylene group, but are these groups unsubstituted? Or may be substituted by one or more substituents L, and Z 21 and Z 22 are each independently —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —COO—, —OCO—. , —CO—NH—, —NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO Is preferably a compound represented by the representative.) The -CH 2 CH 2 -OCO- or a single bond, general formula (II-A-1)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp、Sp、X、X、k3及びk4は各々一般式(II)におけるP、P、Sp、Sp、X、X、k3及びk4と同じ意味を表し、A321は1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z211及びZ221は各々独立して−OCH−、−CHO−、−COO−、−OCO−又は単結合を表し、rは0から4の整数を表す。)で表される化合物がより好ましく、下記の一般式(II−A−11) (In the formula, P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 , k 3 and k 4 are respectively P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 in the general formula (II)). , K3 and k4, and A 321 represents a 1,4-phenylene group or a 1,4-cyclohexylene group, but these groups are unsubstituted or substituted by one or more substituents L Z 211 and Z 221 each independently represent —OCH 2 —, —CH 2 O—, —COO—, —OCO— or a single bond, and r represents an integer of 0 to 4. Is more preferable, and the following general formula (II-A-11)

Figure 2018025752
Figure 2018025752

(式中、P、P、Sp、Sp、X、X、k3及びk4は各々一般式(II)におけるP、P、Sp、Sp、X、X、k3及びk4と同じ意味を表し、rは0から4の整数を表す。)で表される化合物がさらに好ましく、下記の一般式(II−A−111) (In the formula, P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 , k 3 and k 4 are respectively P 3 , P 4 , Sp 3 , Sp 4 , X 3 , X 4 in the general formula (II)). , K3 and k4 have the same meanings, and r represents an integer of 0 to 4.), and the following general formula (II-A-111)

Figure 2018025752
Figure 2018025752

(式中、W及びWは各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、k31及びk41は2から10の整数を表す。)で表される化合物が特に好ましい。 (Wherein, W 1 and W 2 each independently represent a hydrogen atom, a methyl group, a trifluoromethyl group, or a fluorine atom, and k31 and k41 each represent an integer of 2 to 10). preferable.

上記一般式(II)で表される化合物、より好ましくは一般式(II−A)で表される化合物、さらに好ましくは一般式(II−A−11)で表される化合物、特に好ましくは一般式(II−A−111)で表される化合物は1種又は2種以上用いても良いが、光学フィルムを製造する際に使用する当該重合性化合物の合計含有量は、光学フィルムを製造する際に使用する重合性化合物の合計量のうち、1〜99質量%含有することが好ましく、10〜90質量%含有することがより好ましく、20〜80質量%含有することが特に好ましい。得られる光学フィルムの配向性を重視する場合には下限値を20質量%以上とすることが好ましく、30質量%以上とすることがより好ましく、40質量%以上とすることが特に好ましい。また、液晶組成物の保存安定性を重視する場合には上限値を80質量%以下とすることが好ましく、70質量%以下とすることがより好ましく、60質量%以下とすることが特に好ましい。   The compound represented by the general formula (II), more preferably the compound represented by the general formula (II-A), more preferably the compound represented by the general formula (II-A-11), particularly preferably the general The compound represented by the formula (II-A-111) may be used alone or in combination of two or more, but the total content of the polymerizable compound used when producing the optical film produces the optical film. It is preferable to contain 1-99 mass% among the total amount of the polymeric compound used in the case, It is more preferable to contain 10-90 mass%, It is especially preferable to contain 20-80 mass%. When placing importance on the orientation of the obtained optical film, the lower limit is preferably 20% by mass or more, more preferably 30% by mass or more, and particularly preferably 40% by mass or more. In the case where importance is attached to the storage stability of the liquid crystal composition, the upper limit value is preferably 80% by mass or less, more preferably 70% by mass or less, and particularly preferably 60% by mass or less.

その他の一般式(II)で表される化合物として、コレステリック配向性、液晶相温度範囲、フィルムの表面硬度等を調整する目的で下記の式(X−1−1)から式(X−1−3)   As other compounds represented by the general formula (II), the following formulas (X-1-1) to (X-1-) are used for the purpose of adjusting the cholesteric orientation, the liquid crystal phase temperature range, the surface hardness of the film, and the like. 3)

Figure 2018025752
Figure 2018025752

(式中、W101及びW102は各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、k101及びk102は2から10の整数を表す。)で表される化合物を添加することもできる。 In the formula, W 101 and W 102 each independently represents a hydrogen atom, a methyl group, a trifluoromethyl group or a fluorine atom, and k101 and k102 represent an integer of 2 to 10). You can also

また、その他の化合物として下記の式(X−1−4)から式(X−1−7)   Further, as other compounds, the following formulas (X-1-4) to (X-1-7)

Figure 2018025752
Figure 2018025752

(式中、W101及びW102は各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、k101及びk102は2から10の整数を表し、R101は水素原子、炭素原子数1から10のアルキル基又は炭素原子数1から10のアルコキシ基を表す。)で表される化合物が好ましい。 (Wherein, W 101 and W 102 are each independently hydrogen atom, a methyl group, a trifluoromethyl group or a fluorine atom, K101 and k102 is an integer of from 2 to 10, R 101 represents a hydrogen atom, a carbon atom A compound represented by an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms is preferred.

本発明の光学フィルムには、さらにキラル化合物を用いて製造しても良い。キラル化合物は1種又は2種以上用いても良いが、光学フィルムを製造する際に使用するキラル化合物の合計含有量は、光学フィルムを製造する際に使用する重合性化合物の合計量1に対し、0.1〜30質量%含有することが好ましく、1〜20質量%含有することがより好ましく、5〜10質量%含有することが特に好ましい。   The optical film of the present invention may be further produced using a chiral compound. The chiral compound may be used alone or in combination of two or more, but the total content of the chiral compound used when producing the optical film is 1 with respect to the total amount of polymerizable compounds used when producing the optical film. The content is preferably 0.1 to 30% by mass, more preferably 1 to 20% by mass, and particularly preferably 5 to 10% by mass.

キラル化合物としてはイソソルビド構造又はビナフチル構造を有するキラル化合物が好ましく、下記の式(X−2−1)から式(X−2−3)   As the chiral compound, a chiral compound having an isosorbide structure or a binaphthyl structure is preferable, and the following formulas (X-2-1) to (X-2-3)

Figure 2018025752
Figure 2018025752

(式中、Lは一般式(I)におけるLと同じ意味を表し、rは0から4の整数を表し、tは0から2の整数を表し、A101、A102、A103及びA104は各々独立して1,4−フェニレン基、1,4−シクロヘキシレン基又はナフタレン−2,6−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z101、Z102、Z103、Z104、Z105及びZ106は各々独立して−OCH−、−CHO−、−COO−、−OCO−、−CFO−、−OCF−、−CH=CH−COO−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−CH=CH−、−C≡C−又は単結合を表し、m101、m102、m103及びm104は0から5の整数を表し、B101は1,4−フェニレン基、1,4−シクロヘキシレン基又はナフタレン−2,6−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、若しくはB101は1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−COO−、−OCO−、−OCO−O−、−CO−NH−、−NH−CO−、−CH=CH−又は−C≡C−に置き換えられても良い炭素原子数1から20のアルキレン基を表し、R102、R103、R104及びR105は各々独立して水素原子、フッ素原子、塩素原子、シアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、R102、R103、R104及びR105は各々独立してP101−(Sp101−X101k101−で表される基(式中、P101はラジカル重合、カチオン重合又はアニオン重合によって重合する基を表し、Sp101はスペーサー基を表すが、Sp101が複数存在する場合それらは同一であっても異なっていても良く、X101は−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、X101が複数存在する場合それらは同一であっても異なっていても良く、k101は0から10の整数を表す。)を表す。)で表される化合物が好ましく、より具体的には下記の式(X−2−1−1)から式(X−2−3−2) (Wherein L represents the same meaning as L in formula (I), r represents an integer of 0 to 4, t represents an integer of 0 to 2, A 101 , A 102 , A 103 and A 104 Each independently represents a 1,4-phenylene group, a 1,4-cyclohexylene group or a naphthalene-2,6-diyl group, these groups being unsubstituted or substituted by one or more substituents L Z 101 , Z 102 , Z 103 , Z 104 , Z 105 and Z 106 may each independently represent —OCH 2 —, —CH 2 O—, —COO—, —OCO—, —CF 2. O -, - OCF 2 -, - CH = CH-COO -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO- , —CH 2 CH 2 —OCO—, —CH═CH -, - C≡C- or a single bond, m101, M102, M103 and m104 represents an integer of 0 to 5, B 101 is a 1,4-phenylene group, 1,4-cyclohexylene group or a naphthalene-2,6 , 6-diyl groups, these groups may be unsubstituted or substituted by one or more substituents L, or B 101 may be one —CH 2 — or not adjacent 2 Or more of —CH 2 — are each independently —O—, —COO—, —OCO—, —OCO—O—, —CO—NH—, —NH—CO—, —CH═CH— or —C. R represents an alkylene group having 1 to 20 carbon atoms which may be replaced by C-, and R 102 , R 103 , R 104 and R 105 are each independently a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, or Any hydrogen atom in the group is fluorine May be substituted by the child, one -CH 2 - or nonadjacent two or more -CH 2 - are each independently -O -, - OCH 2 -, - CH 2 O -, - CO -, -COO-, -OCO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -OCO-CH = CH-, -COO-CH 2 CH 2 —, —OCO—CH 2 CH 2 —, —CH 2 CH 2 —COO—, —CH 2 CH 2 —OCO—, —COO—CH 2 —, —OCO—CH 2 —, —CH 2 — Represents a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by COO—, —CH 2 —OCO—, —CH═CH—, —CF═CF— or —C≡C—. , or, R 102, R 103, R 104 and R 105 are each independently P 101 (Sp 101 -X 101) k101 - group represented by (wherein, P 101 represents a group capable of polymerization by free radical polymerization, cationic polymerization or anionic polymerization, Sp 101 each represents a spacer group, Sp 101 is plurality of And they may be the same or different, and X 101 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, — CO-S -, - S- CO -, - O-CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S - , - SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 —, —OCO—CH 2 CH 2 —, —CH 2 CH 2 —COO—, —CH 2 CH 2 —OCO—, —COO—CH 2 —, —OCO—CH 2 —, —CH 2 —COO—, —CH 2 —OCO—, —CH═CH—, — N = N—, —CH═N—N═CH—, —CF═CF—, —C≡C— or a single bond, but when there are a plurality of X 101, they may be the same or different. K101 represents an integer of 0 to 10. ). ), And more specifically, the following formulas (X-2-1-1) to (X-2-3-2)

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

(式中、Lは一般式(I)におけるLと同じ意味を表し、rは0から4の整数を表し、W103及びW104は各々独立して水素原子、メチル基、トリフルオロメチル基又はフッ素原子を表し、k103及びk104は2から10の整数を表し、R106及びR107は水素原子、炭素原子数1から10のアルキル基又は炭素原子数1から10のアルコキシ基を表し、R108及びR109は炭素原子数1から10のアルキル基を表す。)で表される化合物がより好ましい。 (Wherein L represents the same meaning as L in formula (I), r represents an integer of 0 to 4, and W 103 and W 104 each independently represent a hydrogen atom, a methyl group, a trifluoromethyl group, or represents a fluorine atom, K103 and k104 is an integer of from 2 to 10, R 106 and R 107 is an alkoxy group of a hydrogen atom, an alkyl group or 1 to 10 carbon atoms number from 1 to 10 carbon atoms, R 108 And R 109 represents an alkyl group having 1 to 10 carbon atoms.).

本願発明の光学フィルムを作製する際に用いる重合性組成物には、当該組成物の液晶性を大きく損なわない程度に、液晶性を示さない重合性化合物を添加することも可能である。具体的には、この技術分野で高分子形成性モノマーあるいは高分子形成性オリゴマーとして認識される化合物であれば特に制限なく使用可能である。具体例として例えば「光硬化技術データブック、材料編(モノマー,オリゴマー,光重合開始剤)」(市村國宏、加藤清視監修、テクノネット社)記載のものが挙げられる。   It is also possible to add a polymerizable compound that does not exhibit liquid crystallinity to the polymerizable composition used in producing the optical film of the present invention to such an extent that the liquid crystallinity of the composition is not significantly impaired. Specifically, any compound that is recognized as a polymer-forming monomer or polymer-forming oligomer in this technical field can be used without particular limitation. Specific examples include those described in “Photocuring Technology Data Book, Materials (Monomer, Oligomer, Photopolymerization Initiator)” (supervised by Kunihiro Ichimura, Kiyosuke Kato, Technonet).

また、本願発明の光学フィルムを作製する際に用いる重合性組成物光重合開始剤を使用しなくても重合させることが可能であるが、目的により光重合開始剤を添加しても構わない。その場合は光重合開始剤の濃度は、光学フィルムを製造する際に使用する重合性化合物の合計量100質量部に対し0.1質量部から15質量部が好ましく、0.2質量部から10質量部がより好ましく、0.4質量部から8質量部がさらに好ましい。光重合開始剤としては、ベンゾインエーテル類、ベンゾフェノン類、アセトフェノン類、ベンジルケタール類、アシルフォスフィンオキサイド類等が挙げられる。光重合開始剤の具体例としては2−メチル−1−(4−メチルチオフェニル)−2−モルホリノプロパン−1−オン(IRGACURE 907)、安息香酸[1−[4−(フェニルチオ)ベンゾイル]ヘプチリデン]アミノ(IRGACURE OXE 01)等が挙げられる。熱重合開始剤としては、アゾ化合物、過酸化物等が挙げられる。熱重合開始剤の具体例としては2,2’−アゾビス(4−メトキシ−2,4−ジメチルバレロニトリル)、2,2’−アゾビス(イソブチロニトリル)等が挙げられる。また、1種類の重合開始剤を用いても良く、2種類以上の重合開始剤を併用して用いても良い。   Moreover, although it is possible to polymerize without using the polymerizable composition photopolymerization initiator used in producing the optical film of the present invention, a photopolymerization initiator may be added depending on the purpose. In that case, the concentration of the photopolymerization initiator is preferably from 0.1 to 15 parts by mass, and from 0.2 to 10 parts by mass, with respect to 100 parts by mass of the total amount of polymerizable compounds used when producing the optical film. Mass parts are more preferred, and 0.4 to 8 parts by mass are even more preferred. Examples of the photopolymerization initiator include benzoin ethers, benzophenones, acetophenones, benzyl ketals, and acylphosphine oxides. Specific examples of the photopolymerization initiator include 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropan-1-one (IRGACURE 907), benzoic acid [1- [4- (phenylthio) benzoyl] heptylidene]. Amino (IRGACURE OXE 01) etc. are mentioned. Examples of the thermal polymerization initiator include azo compounds and peroxides. Specific examples of the thermal polymerization initiator include 2,2'-azobis (4-methoxy-2,4-dimethylvaleronitrile), 2,2'-azobis (isobutyronitrile) and the like. One type of polymerization initiator may be used, or two or more types of polymerization initiators may be used in combination.

また、本発明の光学フィルムを作製する際に用いる重合性組成物には、その保存安定性を向上させるために、安定剤を添加することもできる。使用できる安定剤としては、例えば、ヒドロキノン類、ヒドロキノンモノアルキルエーテル類、第三ブチルカテコール類、ピロガロール類、チオフェノール類、ニトロ化合物類、β−ナフチルアミン類、β−ナフトール類、ニトロソ化合物等が挙げられる。安定剤を使用する場合の添加量は、光学フィルムを製造する際に使用する重合性化合物の合計量100質量部に対して0.005質量部から1質量部の範囲が好ましく、0.02質量部から0.8質量部がより好ましく、0.03質量部から0.5質量部がさらに好ましい。また、1種類の安定剤を用いても良く、2種類以上の安定剤を併用して用いても良い。安定剤としては、具体的には式(X−13−1)から式(X−13−35)   In addition, a stabilizer can be added to the polymerizable composition used when producing the optical film of the present invention in order to improve its storage stability. Examples of the stabilizer that can be used include hydroquinones, hydroquinone monoalkyl ethers, tert-butylcatechols, pyrogallols, thiophenols, nitro compounds, β-naphthylamines, β-naphthols, nitroso compounds, and the like. It is done. The addition amount in the case of using a stabilizer is preferably in the range of 0.005 parts by mass to 1 part by mass with respect to 100 parts by mass of the total amount of polymerizable compounds used for producing the optical film, and 0.02 mass. Part to 0.8 parts by mass is more preferable, and 0.03 parts to 0.5 parts by mass is even more preferable. One kind of stabilizer may be used, or two or more kinds of stabilizers may be used in combination. Specifically, as the stabilizer, the formula (X-13-1) to the formula (X-13-35)

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

(式中、nは0から20の整数を表す。)で表される化合物が好ましい。 (Wherein n represents an integer of 0 to 20) is preferred.

また、本願発明の光学フィルムを作製する際に用いる重合性組成物にはフィルム類、光学素子類、機能性顔料類、医薬品類、化粧品類、コーティング剤類、合成樹脂類等の用途に利用する場合には、その目的に応じて金属、金属錯体、染料、顔料、色素、蛍光材料、燐光材料、界面活性剤、レベリング剤、チキソ剤、ゲル化剤、多糖類、紫外線吸収剤、赤外線吸収剤、抗酸化剤、イオン交換樹脂、酸化チタン等の金属酸化物等を添加することもできる。   In addition, the polymerizable composition used when producing the optical film of the present invention is used for applications such as films, optical elements, functional pigments, pharmaceuticals, cosmetics, coating agents, and synthetic resins. In some cases, metal, metal complex, dye, pigment, pigment, fluorescent material, phosphorescent material, surfactant, leveling agent, thixotropic agent, gelling agent, polysaccharide, ultraviolet absorber, infrared absorber depending on the purpose Further, antioxidants, ion exchange resins, metal oxides such as titanium oxide, and the like can be added.

本願発明の光学フィルムを作製する際に用いる重合性組成物を重合することにより得られるポリマーは種々の用途に利用できる。例えば、本願発明の光学フィルムを作製する際に用いる重合性組成物を、配向させずに重合することにより得られるポリマーは、光散乱板、偏光解消板、モアレ縞防止板として利用可能である。また、配向させた後に重合することにより得られるポリマーは、光学異方性を有しており有用である。このような光学異方体は、例えば、本願発明の光学フィルムを作製する際に用いる重合性組成物を、布等でラビング処理した基板、有機薄膜を形成した基板又はSiOを斜方蒸着した配向膜を有する基板に担持させるか、基板間に挟持させた後、当該重合性組成物を重合することによって製造することができる。 The polymer obtained by polymerizing the polymerizable composition used when producing the optical film of the present invention can be used for various applications. For example, a polymer obtained by polymerizing the polymerizable composition used in producing the optical film of the present invention without orientation can be used as a light scattering plate, a depolarizing plate, and a moire fringe prevention plate. Moreover, the polymer obtained by superposing | polymerizing after orientating has optical anisotropy, and is useful. Such an optical anisotropic body is, for example, a substrate obtained by rubbing a polymerizable composition used for producing the optical film of the present invention with a cloth, a substrate on which an organic thin film is formed, or SiO 2 is obliquely deposited. It can be produced by polymerizing the polymerizable composition after being supported on a substrate having an alignment film or sandwiched between substrates.

重合性組成物を基板上に担持させる際の方法としては、スピンコーティング、ダイコーティング、エクストルージョンコーティング、ロールコーティング、ワイヤーバーコーティング、グラビアコーティング、スプレーコーティング、ディッピング、プリント法等を挙げることができる。またコーティングの際、重合性液晶組成物に有機溶媒を添加しても良い。有機溶媒としては、炭化水素系溶媒、ハロゲン化炭化水素系溶媒、エーテル系溶媒、アルコール系溶媒、ケトン系溶媒、エステル系溶媒、非プロトン性溶媒等を使用することができるが、例えば炭化水素系溶媒としてはトルエン又はヘキサンを、ハロゲン化炭化水素系溶媒としては塩化メチレンを、エーテル系溶媒としてはテトラヒドロフラン、アセトキシ−2−エトキシエタン又はプロピレングリコールモノメチルエーテルアセテートを、アルコール系溶媒としてはメタノール、エタノール又はイソプロパノールを、ケトン系溶媒としてはアセトン、メチルエチルケトン、シクロヘキサノン、γ−ブチルラクトン又はN−メチルピロリジノン類を、エステル系溶媒としては酢酸エチル又はセロソルブを、非プロトン性溶媒としてはジメチルホルムアミド又はアセトニトリルを挙げることができる。これらは単独でも、組み合わせて用いても良く、その蒸気圧と重合性組成物の溶解性を考慮し、適宜選択すれば良い。添加した有機溶媒を揮発させる方法としては、自然乾燥、加熱乾燥、減圧乾燥、減圧加熱乾燥を用いることができる。重合性液晶材料の塗布性をさらに向上させるためには、基板上にポリイミド薄膜等の中間層を設けることや、重合性液晶材料にレベリング剤を添加する事も有効である。基板上にポリイミド薄膜等の中間層を設ける方法は、重合性液晶材料を重合することにより得られるポリマーと基板との密着性を向上させるために有効である。   Examples of the method for supporting the polymerizable composition on the substrate include spin coating, die coating, extrusion coating, roll coating, wire bar coating, gravure coating, spray coating, dipping, and a printing method. Further, an organic solvent may be added to the polymerizable liquid crystal composition during coating. As the organic solvent, hydrocarbon solvents, halogenated hydrocarbon solvents, ether solvents, alcohol solvents, ketone solvents, ester solvents, aprotic solvents and the like can be used. The solvent is toluene or hexane, the halogenated hydrocarbon solvent is methylene chloride, the ether solvent is tetrahydrofuran, acetoxy-2-ethoxyethane or propylene glycol monomethyl ether acetate, and the alcohol solvent is methanol, ethanol or Isopropanol, acetone, methyl ethyl ketone, cyclohexanone, γ-butyl lactone or N-methylpyrrolidinone as the ketone solvent, ethyl acetate or cellosolve as the ester solvent, dimethyl as the aprotic solvent It can be mentioned formamide or acetonitrile. These may be used alone or in combination, and may be appropriately selected in consideration of the vapor pressure and the solubility of the polymerizable composition. As a method for volatilizing the added organic solvent, natural drying, heat drying, reduced pressure drying, or reduced pressure heat drying can be used. In order to further improve the applicability of the polymerizable liquid crystal material, it is also effective to provide an intermediate layer such as a polyimide thin film on the substrate or to add a leveling agent to the polymerizable liquid crystal material. The method of providing an intermediate layer such as a polyimide thin film on a substrate is effective for improving the adhesion between a polymer obtained by polymerizing a polymerizable liquid crystal material and the substrate.

上記以外の配向処理としては、液晶材料の流動配向の利用、電場又は磁場の利用を挙げることができる。これらの配向手段は単独で用いても、また組み合わせて用いても良い。さらに、ラビングに代わる配向処理方法として、光配向法を用いることもできる。基板の形状としては、平板の他に、曲面を構成部分として有していても良い。基板を構成する材料は、有機材料、無機材料を問わずに用いることができる。基板の材料となる有機材料としては、例えば、ポリエチレンテレフタレート、ポリカーボネート、ポリイミド、ポリアミド、ポリメタクリル酸メチル、ポリスチレン、ポリ塩化ビニル、ポリテトラフルオロエチレン、ポリクロロトリフルオロエチレン、ポリアリレート、ポリスルホン、トリアセチルセルロース、セルロース、ポリエーテルエーテルケトン等が挙げられ、また、無機材料としては、例えば、シリコン、ガラス、方解石等が挙げられる。   Examples of the alignment treatment other than the above include use of fluid alignment of a liquid crystal material, use of an electric field or a magnetic field. These orientation means may be used alone or in combination. Furthermore, a photo-alignment method can be used as an alignment treatment method instead of rubbing. As a shape of the substrate, in addition to a flat plate, a curved surface may be included as a constituent part. The material which comprises a board | substrate can be used regardless of an organic material and an inorganic material. Examples of the organic material used as the substrate material include polyethylene terephthalate, polycarbonate, polyimide, polyamide, polymethyl methacrylate, polystyrene, polyvinyl chloride, polytetrafluoroethylene, polychlorotrifluoroethylene, polyarylate, polysulfone, and triacetyl. Cellulose, cellulose, polyetheretherketone and the like can be mentioned, and examples of the inorganic material include silicon, glass and calcite.

本願発明の光学フィルムを作製する際に用いる重合性組成物を重合させる際、迅速に重合が進行することが望ましいため、紫外線又は電子線等の活性エネルギー線を照射することにより重合させる方法が好ましい。紫外線を使用する場合、偏光光源を用いても良く、非偏光光源を用いても良い。また、液晶組成物を2枚の基板間に挟持させて状態で重合を行う場合、少なくとも照射面側の基板は活性エネルギー線に対して適当な透明性を有していなければならない。また、光照射時にマスクを用いて特定の部分のみを重合させた後、電場や磁場又は温度等の条件を変化させることにより、未重合部分の配向状態を変化させて、さらに活性エネルギー線を照射して重合させるという手段を用いても良い。また、照射時の温度は、本発明の光学フィルムを作製する際に用いる重合性組成物の液晶状態が保持される温度範囲内であることが好ましい。特に、光重合によって光学異方体を製造しようとする場合には、意図しない熱重合の誘起を避ける意味からも可能な限り室温に近い温度、即ち、典型的には25℃での温度で重合させることが好ましい。活性エネルギー線の強度は、0.1mW/cm〜2W/cmが好ましい。強度が0.1mW/cm以下の場合、光重合を完了させるのに多大な時間が必要になり生産性が悪化してしまい、2W/cm以上の場合、重合性晶化合物又は重合性組成物が劣化してしまう危険がある。 When polymerizing the polymerizable composition used for producing the optical film of the present invention, it is desirable that the polymerization proceeds rapidly, and therefore a method of polymerizing by irradiating active energy rays such as ultraviolet rays or electron beams is preferable. . When ultraviolet rays are used, a polarized light source or a non-polarized light source may be used. Further, when the polymerization is carried out with the liquid crystal composition sandwiched between two substrates, at least the substrate on the irradiation surface side must have appropriate transparency to the active energy rays. Moreover, after polymerizing only a specific part using a mask at the time of light irradiation, the orientation state of the unpolymerized part is changed by changing conditions such as an electric field, a magnetic field, or temperature, and further irradiation with active energy rays is performed. Then, it is possible to use a means for polymerization. Moreover, it is preferable that the temperature at the time of irradiation exists in the temperature range with which the liquid crystal state of the polymeric composition used when producing the optical film of this invention is hold | maintained. In particular, when an optical anisotropic body is to be produced by photopolymerization, the polymerization is carried out at a temperature as close to room temperature as possible from the viewpoint of avoiding unintentional induction of thermal polymerization, that is, typically at a temperature of 25 ° C. It is preferable to make it. The intensity of the active energy ray is preferably 0.1 mW / cm 2 to 2 W / cm 2 . When the intensity is 0.1 mW / cm 2 or less, a great amount of time is required to complete the photopolymerization, and the productivity deteriorates. When the intensity is 2 W / cm 2 or more, the polymerizable crystal compound or the polymerizable composition There is a risk that things will deteriorate.

重合によって得られた光学異方体は、初期の特性変化を軽減し、安定的な特性発現を図ることを目的として熱処理を施すこともできる。熱処理の温度は50〜250℃の範囲であることが好ましく、熱処理時間は30秒〜12時間の範囲であることが好ましい。   The optical anisotropic body obtained by polymerization can be subjected to heat treatment for the purpose of reducing initial characteristic changes and achieving stable characteristic expression. The heat treatment temperature is preferably in the range of 50 to 250 ° C., and the heat treatment time is preferably in the range of 30 seconds to 12 hours.

このような方法によって製造される当該光学異方体は、基板から剥離して単体で用いても、剥離せずに用いても良い。また、得られた光学異方体を積層しても、他の基板に貼り合わせて用いてもよい。   The optical anisotropic body manufactured by such a method may be peeled off from the substrate and used alone or without being peeled off. Further, the obtained optical anisotropic bodies may be laminated or bonded to another substrate for use.

以下、実施例を挙げて本発明を更に記述するが、本発明はこれらの実施例に限定されるものではない。また、以下の実施例及び比較例の組成物における「%」は『質量%』を意味する。各工程において酸素及び/又は水分に不安定な物質を取り扱う際は、窒素ガス、アルゴンガス等の不活性ガス中で作業を行うことが好ましい。通常の後処理とは、反応液から目的の化合物を得るために行う作業であり、反応のクエンチ、分液・抽出、中和、洗浄、乾燥、濃縮等の当業者間において通常行われている作業を意味する。
(合成例1)式(A−1−1)から式(A−1−3)で表される化合物によって構成される混合物(A−1)の製造
EXAMPLES Hereinafter, although an Example is given and this invention is further described, this invention is not limited to these Examples. Further, “%” in the compositions of the following Examples and Comparative Examples means “% by mass”. When handling a substance unstable to oxygen and / or moisture in each step, it is preferable to work in an inert gas such as nitrogen gas or argon gas. Normal post-treatment is an operation performed to obtain a target compound from a reaction solution, and is usually performed among those skilled in the art such as reaction quenching, liquid separation / extraction, neutralization, washing, drying, and concentration. Means work.
(Synthesis example 1) Manufacture of the mixture (A-1) comprised by the compound represented by Formula (A-1-3) from Formula (A-1-1).

Figure 2018025752
Figure 2018025752

反応容器に式(A−1−a)で表される化合物(混合物)5.0g、無水コハク酸4.2g、N,N−ジメチルアミノピリジン0.5g、2,6−ジ−tert−ブチル−4−メチルフェノール25mg、ジクロロメタン40mLを加え40℃で12時間加熱撹拌した。冷却し水40mLを加え室温で1時間撹拌した。分液処理した後、5%塩酸及び飽和食塩水で順次洗浄した。硫酸ナトリウムで乾燥させた後、溶媒を留去することにより、式(A−1−b)で表される化合物(混合物)8.4gを得た。   In a reaction vessel, 5.0 g of the compound (mixture) represented by the formula (A-1-a), 4.2 g of succinic anhydride, 0.5 g of N, N-dimethylaminopyridine, 2,6-di-tert-butyl -25 mg of -4-methylphenol and 40 mL of dichloromethane were added and stirred with heating at 40 ° C. for 12 hours. After cooling, 40 mL of water was added and stirred at room temperature for 1 hour. After separation treatment, it was washed successively with 5% hydrochloric acid and saturated brine. After drying with sodium sulfate, the solvent was distilled off to obtain 8.4 g of a compound (mixture) represented by the formula (A-1-b).

反応容器に式(A−1−b)で表される化合物(混合物)8.4g、2,6−ジ−tert−ブチル−4−メチルフェノール42mg、酢酸エチル24mL、N,N−ジメチルアセトアミド8mLを加えた。5℃に冷却し塩化チオニル4.6gを滴下し5℃で1時間撹拌した。2−(4−ヒドロキシフェニル)エタノール5.0gをN,N−ジメチルアセトアミド25mLに溶解させた溶液を滴下し室温で12時間撹拌した。反応液を水に注ぎ、酢酸エチルで抽出した後、5%塩酸、水及び食塩水で順次で順次洗浄した。硫酸ナトリウムで乾燥させた後、溶媒を留去することにより、式(A−1−c)で表される化合物(混合物)12.1gを得た。   8.4 g of a compound (mixture) represented by the formula (A-1-b) in a reaction vessel, 42 mg of 2,6-di-tert-butyl-4-methylphenol, 24 mL of ethyl acetate, 8 mL of N, N-dimethylacetamide Was added. After cooling to 5 ° C., 4.6 g of thionyl chloride was added dropwise, and the mixture was stirred at 5 ° C. for 1 hour. A solution prepared by dissolving 5.0 g of 2- (4-hydroxyphenyl) ethanol in 25 mL of N, N-dimethylacetamide was added dropwise and stirred at room temperature for 12 hours. The reaction solution was poured into water, extracted with ethyl acetate, and then washed sequentially with 5% hydrochloric acid, water and brine. After drying with sodium sulfate, the solvent was distilled off to obtain 12.1 g of a compound (mixture) represented by the formula (A-1-c).

反応容器にtrans−1,4−シクロヘキサンジカルボン酸1.0g、メタンスルホン酸クロリド1.3g、テトラヒドロフラン5mL、N,N−ジメチルアセトアミド5mLを加えた。トリエチルアミン1.2gを滴下し室温で2時間撹拌した。式(A−1−c)で表される化合物(混合物)4.1gと2,6−ジ−tert−ブチル−4−メチルフェノール20mgをテトラヒドロフラン12mLに溶解させた溶液を滴下した。トリエチルアミン1.2gを滴下し室温で12時間撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出し、5%塩酸及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(A−1)で表される化合物(混合物)を得た。
LCMS:m/z 837[M+1]
(合成例2)式(A−2−1)から式(A−2−3)で表される化合物によって構成される混合物(A−2)の製造
To the reaction vessel, 1.0 g of trans-1,4-cyclohexanedicarboxylic acid, 1.3 g of methanesulfonic acid chloride, 5 mL of tetrahydrofuran, and 5 mL of N, N-dimethylacetamide were added. Triethylamine 1.2g was dripped and it stirred at room temperature for 2 hours. A solution prepared by dissolving 4.1 g of the compound (mixture) represented by the formula (A-1-c) and 20 mg of 2,6-di-tert-butyl-4-methylphenol in 12 mL of tetrahydrofuran was added dropwise. Triethylamine 1.2g was dripped and it stirred at room temperature for 12 hours. The reaction solution was poured into water, extracted with dichloromethane, and washed successively with 5% hydrochloric acid and brine. Purification was performed by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) to obtain a compound (mixture) represented by the formula (A-1).
LCMS: m / z 837 [M + 1]
Synthesis Example 2 Production of Mixture (A-2) Consists of Compounds Represented by Formula (A-2-3) to Formula (A-2-3)

Figure 2018025752
Figure 2018025752

合成例1において式(A−1−a)で表される化合物(混合物)を式(A−2−a)で表される化合物(混合物)に置き換えた以外は同様の方法によって、式(A−2−b)で表される化合物(混合物)を製造した。   In the same manner as in Synthesis Example 1, except that the compound (mixture) represented by the formula (A-1-a) was replaced with the compound (mixture) represented by the formula (A-2-a), the formula (A A compound (mixture) represented by -2-b) was produced.

窒素雰囲気下、反応容器に式(A−2−b)で表される化合物(混合物)3.0g、4−テトラヒドロピラニルオキシフェノール2.4g、N,N−ジメチルアミノピリジン0.1g、ジクロロメタン30mLを加えた。氷冷しながらジイソプロピルカルボジイミド1.7gを滴下し室温で8時間撹拌した。1%塩酸、水及び食塩水で洗浄した後、カラムクロマトグラフィー(アルミナ、ジクロロメタン)により精製を行い、式(A−2−c)で表される化合物(混合物)4.1gを得た。   Under a nitrogen atmosphere, 3.0 g of the compound (mixture) represented by the formula (A-2-b), 2.4 g of 4-tetrahydropyranyloxyphenol, 0.1 g of N, N-dimethylaminopyridine, dichloromethane in a reaction vessel 30 mL was added. While cooling with ice, 1.7 g of diisopropylcarbodiimide was added dropwise and stirred at room temperature for 8 hours. After washing with 1% hydrochloric acid, water and brine, purification was performed by column chromatography (alumina, dichloromethane) to obtain 4.1 g of a compound (mixture) represented by the formula (A-2-c).

反応容器に式(A−2−c)で表される化合物(混合物)4.1g、テトラヒドロフラン20mL、メタノール20mLを加えた。濃塩酸0.2mLを加え室温で8時間撹拌した。酢酸エチルで希釈した後、水及び食塩水で洗浄した。カラムクロマトグラフィー(シリカゲル、酢酸エチル)により精製を行い、式(A−2−d)で表される化合物(混合物)3.0gを得た。   To the reaction vessel, 4.1 g of a compound (mixture) represented by the formula (A-2-c), 20 mL of tetrahydrofuran, and 20 mL of methanol were added. Concentrated hydrochloric acid 0.2mL was added and it stirred at room temperature for 8 hours. After diluting with ethyl acetate, it was washed with water and brine. Purification was performed by column chromatography (silica gel, ethyl acetate) to obtain 3.0 g of a compound (mixture) represented by the formula (A-2-d).

合成例1において式(A−1−c)で表される化合物(混合物)を式(A−2−d)で表される化合物(混合物)に置き換えた以外は同様の方法によって、式(A−2)で表される化合物(混合物)を製造した。
LCMS:m/z 809[M+1]
(合成例3)式(A−3−1)から式(A−3−3)で表される化合物によって構成される混合物(A−3)の製造
In the same manner as in Synthesis Example 1, except that the compound (mixture) represented by the formula (A-1-c) was replaced with the compound (mixture) represented by the formula (A-2-d), the formula (A -2) was produced (mixture).
LCMS: m / z 809 [M + 1]
(Synthesis Example 3) Production of mixture (A-3) composed of compounds represented by formula (A-3-3) to formula (A-3-3)

Figure 2018025752
Figure 2018025752

窒素雰囲気下、反応容器に式(A−3−a)で表される化合物20.0g、ジイソプロピルエチルアミン14.3g、ジクロロメタン200mLを加えた。氷冷しながら塩化アクリロイル10.0gを滴下し室温で6時間撹拌した。反応液を水に注ぎ、分液処理した後、メタノールと水の混合溶媒及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、酢酸エチル)により精製を行い、式(A−3−b)で表される化合物(混合物)11.5gを得た。   Under a nitrogen atmosphere, 20.0 g of the compound represented by the formula (A-3-a), 14.3 g of diisopropylethylamine, and 200 mL of dichloromethane were added to the reaction vessel. While cooling with ice, 10.0 g of acryloyl chloride was added dropwise and stirred at room temperature for 6 hours. The reaction solution was poured into water and subjected to a liquid separation treatment, and then washed sequentially with a mixed solvent of methanol and water and brine. Purification was performed by column chromatography (silica gel, ethyl acetate) to obtain 11.5 g of a compound (mixture) represented by the formula (A-3-b).

合成例2において式(A−2−a)で表される化合物(混合物)を式(A−3−b)で表される化合物(混合物)に置き換えた以外は同様の方法によって、式(A−3)で表される化合物(混合物)を製造した。
LCMS:m/z 809[M+1]
(合成例4)式(A−4)で表される化合物の製造
In the same manner as in Synthesis Example 2, except that the compound (mixture) represented by the formula (A-2-a) was replaced with the compound (mixture) represented by the formula (A-3-b), the formula (A The compound (mixture) represented by -3) was produced.
LCMS: m / z 809 [M + 1]
Synthesis Example 4 Production of Compound Represented by Formula (A-4)

Figure 2018025752
Figure 2018025752

反応容器に式(A−4−a)で表される化合物5.0g、3−クロロプロパノール2.4g、炭酸カリウム5.3g、N,N−ジメチルホルムアミド40mLを加え、90℃で12時間加熱撹拌した。冷却し水に注いだ後、酢酸エチルで抽出した。水及び食塩水で順次洗浄した。カラムクロマトグラフィー(アルミナ、酢酸エチル)により精製を行い、式(A−4−b)で表される化合物5.2gを得た。   To the reaction vessel is added 5.0 g of the compound represented by the formula (A-4-a), 2.4 g of 3-chloropropanol, 5.3 g of potassium carbonate, and 40 mL of N, N-dimethylformamide, and the mixture is heated at 90 ° C. for 12 hours. Stir. After cooling and pouring into water, the mixture was extracted with ethyl acetate. Washed sequentially with water and brine. Purification was performed by column chromatography (alumina, ethyl acetate) to obtain 5.2 g of a compound represented by the formula (A-4-b).

合成例3において式(A−3−a)で表される化合物を式(A−4−c)で表される化合物に置き換えた以外は同様の方法によって、式(A−4)で表される化合物を製造した。
LCMS:m/z 925[M+1]
(合成例5)式(A−5−1)から式(A−5−3)で表される化合物によって構成される混合物(A−5)の製造
A compound represented by the formula (A-4) is represented by the same method except that the compound represented by the formula (A-3-a) is replaced by a compound represented by the formula (A-4-c) in Synthesis Example 3. A compound was prepared.
LCMS: m / z 925 [M + 1]
(Synthesis example 5) Manufacture of the mixture (A-5) comprised by the compound represented by Formula (A-5-3) from Formula (A-5-1).

Figure 2018025752
Figure 2018025752

合成例3において式(A−3−a)で表される化合物を式(A−5−a)で表される化合物に置き換えた以外は同様の方法によって、式(A−5−c)で表される化合物(混合物)を製造した。   In the same manner as in Synthesis Example 3 except that the compound represented by the formula (A-3-a) is replaced with the compound represented by the formula (A-5-a), the compound represented by the formula (A-5-c) The represented compound (mixture) was prepared.

窒素雰囲気下、反応容器に式(A−5−d)で表される化合物5.0g、式(A−5−e)で表される化合物3.5g、炭酸カリウム3.9g、エタノール50mL、水30mL、テトラキス(トリフェニルホスフィン)パラジウム(0)0.4gを加え12時間加熱還流させた。冷却した後、酢酸エチルで希釈し、5%塩酸、水及び食塩水で洗浄した。カラムクロマトグラフィー(アルミナ、酢酸エチル)及び再結晶(トルエン/エタノール)により精製を行い、式(A−5−f)で表される化合物4.3gを得た。   Under a nitrogen atmosphere, 5.0 g of the compound represented by the formula (A-5-d), 3.5 g of the compound represented by the formula (A-5-e), 3.9 g of potassium carbonate, 50 mL of ethanol, Water (30 mL) and tetrakis (triphenylphosphine) palladium (0) (0.4 g) were added, and the mixture was heated to reflux for 12 hours. After cooling, it was diluted with ethyl acetate and washed with 5% hydrochloric acid, water and brine. Purification was performed by column chromatography (alumina, ethyl acetate) and recrystallization (toluene / ethanol) to obtain 4.3 g of a compound represented by the formula (A-5-f).

合成例1において式(A−1−b)で表される化合物(混合物)を式(A−5−c)で表される化合物(混合物)に、2−(4−ヒドロキシフェニル)エタノールを式(A−5−f)で表される化合物に置き換えた以外は同様の方法によって、式(A−5)で表される化合物(混合物)を製造した。
LCMS:m/z 947[M+1]
(合成例6)式(A−6−1)から式(A−6−3)で表される化合物によって構成される混合物(A−6)の製造
In Synthesis Example 1, the compound (mixture) represented by the formula (A-1-b) is converted into the compound (mixture) represented by the formula (A-5-c), and 2- (4-hydroxyphenyl) ethanol is represented by the formula. A compound (mixture) represented by the formula (A-5) was produced by the same method except that the compound represented by (A-5-f) was replaced.
LCMS: m / z 947 [M + 1]
(Synthesis Example 6) Production of a mixture (A-6) composed of a compound represented by the formula (A-6-3) from the formula (A-6-1)

Figure 2018025752
Figure 2018025752

合成例3において式(A−3−a)で表される化合物を式(A−6−a)で表される化合物に置き換えた以外は同様の方法によって、式(A−6−c)で表される化合物(混合物)を製造した。   In the same manner as in Synthesis Example 3 except that the compound represented by the formula (A-3-a) is replaced by the compound represented by the formula (A-6-a), the compound represented by the formula (A-6-c) The represented compound (mixture) was prepared.

合成例1において式(A−1−b)で表される化合物を式(A−6−c)で表される化合物(混合物)に、2−(4−ヒドロキシフェニル)エタノールをtrans−4−(2−ヒドロキシエチル)シクロヘキサノールに置き換えた以外は同様の方法によって、式(A−6−d)で表される化合物(混合物)を製造した。   In Synthesis Example 1, the compound represented by the formula (A-1-b) is converted into the compound (mixture) represented by the formula (A-6-c), and 2- (4-hydroxyphenyl) ethanol is trans-4- A compound (mixture) represented by the formula (A-6-d) was produced by the same method except that (2-hydroxyethyl) cyclohexanol was used.

反応容器にtrans−1,4−シクロヘキサンジカルボン酸9.0g、メタンスルホン酸クロリド2.0g、テトラヒドロフラン20mL、N,N−ジメチルアセトアミド20mLを加えた。トリエチルアミン1.8gを滴下し室温で2時間撹拌した。式(A−6−d)で表される化合物(混合物)6.3gと2,6−ジ−tert−ブチル−4−メチルフェノール20mgをテトラヒドロフラン12mLに溶解させた溶液を滴下した。N,N−ジメチルアミノピリジン0.6gを加えた後トリエチルアミン1.8gを滴下し室温で12時間撹拌した。反応液を水に注ぎ、酢酸エチルで抽出し、5%塩酸及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、酢酸エチル)及び再結晶(酢酸エチル/ヘキサン)により精製を行い、式(A−6−e)で表される化合物(混合物)6.8gを得た。   To the reaction vessel, 9.0 g of trans-1,4-cyclohexanedicarboxylic acid, 2.0 g of methanesulfonic acid chloride, 20 mL of tetrahydrofuran, and 20 mL of N, N-dimethylacetamide were added. Triethylamine 1.8g was dripped and it stirred at room temperature for 2 hours. A solution prepared by dissolving 6.3 g of the compound (mixture) represented by the formula (A-6-d) and 20 mg of 2,6-di-tert-butyl-4-methylphenol in 12 mL of tetrahydrofuran was added dropwise. After adding 0.6 g of N, N-dimethylaminopyridine, 1.8 g of triethylamine was added dropwise, followed by stirring at room temperature for 12 hours. The reaction mixture was poured into water, extracted with ethyl acetate, and washed successively with 5% hydrochloric acid and brine. Purification was performed by column chromatography (silica gel, ethyl acetate) and recrystallization (ethyl acetate / hexane) to obtain 6.8 g of a compound (mixture) represented by the formula (A-6-e).

反応容器に式(A−6−e)で表される化合物(混合物)6.8g、2,6−ジ−tert−ブチル−4−メチルフェノール7mg、酢酸エチル35mL、N,N−ジメチルアセトアミド14mLを加えた。5℃に冷却し塩化チオニル2.7gを滴下し5℃で1時間撹拌した。N,N−ジイソプロピルエチルアミン2.0gを滴下した。2−メチル−1,4−ヒドロキノン0.9gをテトラヒドロフラン5mLに溶解させた溶液及びN,N−ジメチルアミノピリジン0.2gを加えた。5℃でN,N−ジイソプロピルエチルアミン4.7gを滴下し室温で5時間撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出した後、5%塩酸、水及び食塩水で順次で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(A−6)で表される化合物(混合物)6.9gを得た。
LCMS:m/z 1193[M+1]
(合成例7)式(A−7−1)から式(A−7−3)で表される化合物によって構成される混合物(A−7)の製造
6.8 g of a compound (mixture) represented by the formula (A-6-e) in a reaction vessel, 7 mg of 2,6-di-tert-butyl-4-methylphenol, 35 mL of ethyl acetate, 14 mL of N, N-dimethylacetamide Was added. The mixture was cooled to 5 ° C., 2.7 g of thionyl chloride was added dropwise, and the mixture was stirred at 5 ° C. for 1 hour. 2.0 g of N, N-diisopropylethylamine was added dropwise. A solution prepared by dissolving 0.9 g of 2-methyl-1,4-hydroquinone in 5 mL of tetrahydrofuran and 0.2 g of N, N-dimethylaminopyridine were added. At 5 ° C., 4.7 g of N, N-diisopropylethylamine was added dropwise and stirred at room temperature for 5 hours. The reaction solution was poured into water, extracted with dichloromethane, and then washed sequentially with 5% hydrochloric acid, water and brine. Purification by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) gave 6.9 g of a compound (mixture) represented by the formula (A-6).
LCMS: m / z 1193 [M + 1]
(Synthesis example 7) Manufacture of the mixture (A-7) comprised by the compound represented by Formula (A-7-3) from Formula (A-7-1)

Figure 2018025752
Figure 2018025752

合成例6において式(A−6−d)で表される化合物(混合物)を式(A−7−a)で表される化合物(混合物)に置き換えた以外は同様の方法によって、式(A−7)で表される化合物(混合物)を製造した。
LCMS:m/z 1097[M+1]
(合成例8)式(A−8−1)から式(A−8−3)で表される化合物によって構成される混合物(A−8)の製造
In the same manner as in Synthesis Example 6 except that the compound (mixture) represented by the formula (A-6-d) was replaced with the compound (mixture) represented by the formula (A-7-a), the formula (A The compound (mixture) represented by -7) was produced.
LCMS: m / z 1097 [M + 1]
(Synthesis Example 8) Production of a mixture (A-8) composed of a compound represented by the formula (A-8-3) from the formula (A-8-1)

Figure 2018025752
Figure 2018025752

合成例1において2−(4−ヒドロキシフェニル)エタノールを1,4−ブタンジオールに置き換えた以外は同様の方法によって、式(A−8−b)で表される化合物(混合物)を製造した。   A compound (mixture) represented by the formula (A-8-b) was produced by the same method except that 2- (4-hydroxyphenyl) ethanol was replaced with 1,4-butanediol in Synthesis Example 1.

合成例6において式(A−6−d)で表される化合物(混合物)を式(A−8−b)で表される化合物(混合物)に、2−メチル−1,4−ヒドロキノンを2−アセチル−1,4−ヒドロキノンに置き換えた以外は同様の方法によって、式(A−8)で表される化合物(混合物)を製造した。
LCMS:m/z 1029[M+1]
(合成例9)式(A−9−1)から式(A−9−3)で表される化合物によって構成される混合物(A−9)の製造
In Synthesis Example 6, the compound (mixture) represented by the formula (A-6-d) is changed to the compound (mixture) represented by the formula (A-8-b), and 2-methyl-1,4-hydroquinone is added to 2 A compound (mixture) represented by the formula (A-8) was produced by the same method except that -acetyl-1,4-hydroquinone was used.
LCMS: m / z 1029 [M + 1]
(Synthesis example 9) Manufacture of the mixture (A-9) comprised by the compound represented by Formula (A-9-3) from Formula (A-9-1).

Figure 2018025752
Figure 2018025752

合成例3において式(A−3−a)で表される化合物を式(A−9−a)で表される化合物に、4−テトラヒドロピラニルオキシフェノールを4−ヒドロキシベンズアルデヒドに置き換えた以外は同様の方法によって、式(A−9−d)で表される化合物(混合物)を製造した。   In Synthesis Example 3, the compound represented by the formula (A-3-a) was replaced with the compound represented by the formula (A-9-a), and 4-tetrahydropyranyloxyphenol was replaced with 4-hydroxybenzaldehyde. A compound (mixture) represented by the formula (A-9-d) was produced by the same method.

反応容器に式(A−9−d)で表される化合物(混合物)5.0g、メタノール20mL、リン酸二水素ナトリウム二水和物1.6gを水20mLに溶解させた水溶液、30%過酸化水素水2.3gを加えた。亜塩素酸ナトリウム1.5gを水15mLに溶解させた水溶液を滴下し50℃で10時間加熱撹拌した。冷却し水を加え酢酸エチルで抽出した。5%塩酸及び食塩水で洗浄した後、硫酸ナトリウムで乾燥させ溶媒を留去することによって式(A−9−e)で表される化合物(混合物)4.2gを得た。   An aqueous solution in which 5.0 g of a compound (mixture) represented by the formula (A-9-d), 20 mL of methanol, and 1.6 g of sodium dihydrogen phosphate dihydrate are dissolved in 20 mL of water in a reaction vessel, 30% excess 2.3 g of hydrogen oxide water was added. An aqueous solution in which 1.5 g of sodium chlorite was dissolved in 15 mL of water was dropped, and the mixture was heated and stirred at 50 ° C. for 10 hours. After cooling, water was added and extracted with ethyl acetate. After washing with 5% hydrochloric acid and brine, it was dried over sodium sulfate and the solvent was distilled off to obtain 4.2 g of a compound (mixture) represented by the formula (A-9-e).

合成例1において式(A−1−c)で表される化合物(混合物)を4,4’−ジヒドロキシビフェニルに、trans−1,4−シクロヘキサンジカルボン酸を式(A−9−e)で表される化合物に置き換えた以外は同様の方法によって、式(A−9)で表される化合物(混合物)を製造した。
LCMS:m/z 963[M+1]
(合成例10)式(A−10−1)から式(A−10−3)で表される化合物によって構成される混合物(A−10)の製造
In Synthesis Example 1, the compound (mixture) represented by the formula (A-1-c) is represented by 4,4′-dihydroxybiphenyl, and trans-1,4-cyclohexanedicarboxylic acid is represented by the formula (A-9-e). A compound (mixture) represented by the formula (A-9) was produced by the same method except that the compound was replaced with the above compound.
LCMS: m / z 963 [M + 1]
(Synthesis Example 10) Production of a mixture (A-10) composed of a compound represented by the formula (A-10-3) to the formula (A-10-3)

Figure 2018025752
Figure 2018025752

合成例6において式(A−6−a)で表される化合物を式(A−10−a)で表される化合物に、塩化アクリロイルを塩化メタクリロイルに、trans−4−(2−ヒドロキシエチル)シクロヘキサノールをエチレングリコールに、2−メチル−1,4−ヒドロキノンを2,5−ジヒドロキシ安息香酸メチルに置き換えた以外は同様の方法によって、式(A−10)で表される化合物(混合物)を製造した。
LCMS:m/z 1077[M+1]
(合成例11)式(B−1−1)及び式(B−1−2)で表される化合物によって構成される混合物(B−1)の製造
In Synthesis Example 6, the compound represented by the formula (A-6-a) is changed to the compound represented by the formula (A-10-a), acryloyl chloride is changed to methacryloyl chloride, and trans-4- (2-hydroxyethyl) is changed. A compound (mixture) represented by the formula (A-10) was prepared in the same manner except that cyclohexanol was replaced with ethylene glycol and 2-methyl-1,4-hydroquinone was replaced with methyl 2,5-dihydroxybenzoate. Manufactured.
LCMS: m / z 1077 [M + 1]
(Synthesis example 11) Manufacture of the mixture (B-1) comprised by the compound represented by Formula (B-1-1) and Formula (B-1-2).

Figure 2018025752
Figure 2018025752

反応容器にtrans−4−(trans−4−プロピルシクロヘキシル)シクロヘキサンカルボン酸3.0g、メタンスルホン酸クロリド1.4g、テトラヒドロフラン20mL、N,N−ジメチルアセトアミド20mLを加えた。トリエチルアミン1.3gを滴下し室温で2時間撹拌した。式(B−1−a)で表される化合物(混合物)4.2gと2,6−ジ−tert−ブチル−4−メチルフェノール20mgをテトラヒドロフラン12mLに溶解させた溶液を滴下した。N,N−ジメチルアミノピリジン0.6gを加えた後トリエチルアミン1.5gを滴下し室温で12時間撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出し、5%塩酸及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(B−1)で表される化合物(混合物)4.9gを得た。
LCMS:m/z 585[M+1]
(合成例12)式(B−2−1)及び式(B−2−2)で表される化合物によって構成される混合物(B−2)の製造
To the reaction vessel, trans-4- (trans-4-propylcyclohexyl) cyclohexanecarboxylic acid (3.0 g), methanesulfonic acid chloride (1.4 g), tetrahydrofuran (20 mL), and N, N-dimethylacetamide (20 mL) were added. Triethylamine 1.3g was dripped and it stirred at room temperature for 2 hours. A solution prepared by dissolving 4.2 g of the compound (mixture) represented by the formula (B-1-a) and 20 mg of 2,6-di-tert-butyl-4-methylphenol in 12 mL of tetrahydrofuran was added dropwise. After adding 0.6 g of N, N-dimethylaminopyridine, 1.5 g of triethylamine was added dropwise, followed by stirring at room temperature for 12 hours. The reaction solution was poured into water, extracted with dichloromethane, and washed successively with 5% hydrochloric acid and brine. Purification was performed by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) to obtain 4.9 g of a compound (mixture) represented by the formula (B-1).
LCMS: m / z 585 [M + 1]
(Synthesis example 12) Manufacture of the mixture (B-2) comprised by the compound represented by Formula (B-2-1) and Formula (B-2-2)

Figure 2018025752
Figure 2018025752

合成例6において式(A−6−d)で表される化合物を式(B−2−a)で表される化合物に置き換えた以外は同様の方法によって、式(B−2−b)で表される化合物(混合物)を製造した。   In the same manner as in Synthesis Example 6 except that the compound represented by the formula (A-6-d) was replaced with the compound represented by the formula (B-2-a), the compound represented by the formula (B-2-b) The represented compound (mixture) was prepared.

反応容器に式(B−2−b)で表される化合物(混合物)5.0g、2,6−ジ−tert−ブチル−4−メチルフェノール7mg、酢酸エチル35mL、N,N−ジメチルアセトアミド14mLを加えた。5℃に冷却し塩化チオニル1.5gを滴下し5℃で1時間撹拌した。N,N−ジイソプロピルエチルアミン2.0gを滴下した。4−(trans−4−ペンチルシクロヘキシル)フェノール2.5gをテトラヒドロフラン5mLに溶解させた溶液及びN,N−ジメチルアミノピリジン0.2gを加えた。5℃でN,N−ジイソプロピルエチルアミン4.7gを滴下し室温で5時間撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出した後、5%塩酸、水及び食塩水で順次で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(B−2)で表される化合物(混合物)5.9gを得た。
LCMS:m/z 719[M+1]
(合成例13)式(B−3−1)及び式(B−3−2)で表される化合物によって構成される混合物(B−3)の製造
In a reaction vessel, 5.0 g of the compound (mixture) represented by the formula (B-2-b), 7 mg of 2,6-di-tert-butyl-4-methylphenol, 35 mL of ethyl acetate, 14 mL of N, N-dimethylacetamide Was added. The mixture was cooled to 5 ° C., 1.5 g of thionyl chloride was added dropwise, and the mixture was stirred at 5 ° C. for 1 hour. 2.0 g of N, N-diisopropylethylamine was added dropwise. A solution in which 2.5 g of 4- (trans-4-pentylcyclohexyl) phenol was dissolved in 5 mL of tetrahydrofuran and 0.2 g of N, N-dimethylaminopyridine were added. At 5 ° C., 4.7 g of N, N-diisopropylethylamine was added dropwise and stirred at room temperature for 5 hours. The reaction solution was poured into water, extracted with dichloromethane, and then washed sequentially with 5% hydrochloric acid, water and brine. Purification was performed by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) to obtain 5.9 g of a compound (mixture) represented by the formula (B-2).
LCMS: m / z 719 [M + 1]
(Synthesis example 13) Manufacture of the mixture (B-3) comprised by the compound represented by Formula (B-3-1) and Formula (B-3-2).

Figure 2018025752
Figure 2018025752

合成例9において式(A−9−c)で表される化合物(混合物)を式(B−3−a)で表される化合物(混合物)に置き換えた以外は同様の方法によって、式(B−3−c)で表される化合物(混合物)を製造した。   In the same manner as in Synthesis Example 9 except that the compound (mixture) represented by the formula (A-9-c) was replaced with the compound (mixture) represented by the formula (B-3-a), the formula (B A compound (mixture) represented by -3-c) was produced.

特開2013−253041号公報に記載の方法によって、式(B−3−d)で表される化合物を製造した。   A compound represented by the formula (B-3-d) was produced by the method described in JP2013-253041A.

合成例12において式(B−2−b)で表される化合物(混合物)を式(B−3−c)で表される化合物(混合物)に、4−(trans−4−ペンチルシクロヘキシル)フェノールを式(B−3−d)で表される化合物に置き換えた以外は同様の方法によって、式(B−3)で表される化合物(混合物)を製造した。
LCMS:m/z 625[M+1]
(合成例14)式(B−4−1)及び式(B−4−2)で表される化合物によって構成される混合物(B−4)の製造
In Synthesis Example 12, the compound (mixture) represented by the formula (B-2-b) is converted into a compound (mixture) represented by the formula (B-3-c) and 4- (trans-4-pentylcyclohexyl) phenol. A compound (mixture) represented by the formula (B-3) was produced by the same method except that was replaced with a compound represented by the formula (B-3-d).
LCMS: m / z 625 [M + 1]
(Synthesis example 14) Manufacture of the mixture (B-4) comprised by the compound represented by Formula (B-4-1) and Formula (B-4-2).

Figure 2018025752
Figure 2018025752

反応容器に式(B−4−a)で表される化合物5.0g、3−クロロプロパノール4.6g、炭酸カリウム8.5g、N,N−ジメチルホルムアミド50mLを加え90℃で12時間加熱撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)により精製を行い、式(B−4−b)で表される化合物5.9gを得た。   To the reaction vessel was added 5.0 g of the compound represented by the formula (B-4-a), 4.6 g of 3-chloropropanol, 8.5 g of potassium carbonate, and 50 mL of N, N-dimethylformamide, and the mixture was heated and stirred at 90 ° C. for 12 hours. did. The reaction mixture was poured into water and extracted with dichloromethane. Purification was performed by column chromatography (silica gel, dichloromethane) to obtain 5.9 g of a compound represented by the formula (B-4-b).

合成例4において式(A−4−c)で表される化合物(混合物)を式(B−4−c)で表される化合物(混合物)に、式(A−4−b)で表される化合物を式(B−4−b)で表される化合物に置き換えた以外は同様の方法によって、式(B−4−f)で表される化合物(混合物)を製造した。   In Synthesis Example 4, the compound (mixture) represented by the formula (A-4-c) is represented by the formula (A-4-b) to the compound (mixture) represented by the formula (B-4-c). The compound (mixture) represented by the formula (B-4-f) was produced by the same method except that the compound represented by the formula (B-4-b) was replaced.

合成例13において式(B−3−b)で表される化合物(混合物)を式(B−4−f)で表される化合物(混合物)に、式(B−3−d)で表される化合物を4−シアノ−4’−ヒドロキシビフェニルに置き換えた以外は同様の方法によって、式(B−4)で表される化合物(混合物)を製造した。
LCMS:m/z 628[M+1]
(合成例15)式(B−5−1)及び式(B−5−2)で表される化合物によって構成される混合物(B−5)の製造
In Synthesis Example 13, the compound (mixture) represented by the formula (B-3-b) is represented by the formula (B-3-d) to the compound (mixture) represented by the formula (B-4-f). A compound (mixture) represented by the formula (B-4) was produced by the same method except that 4-cyano-4′-hydroxybiphenyl was substituted.
LCMS: m / z 628 [M + 1]
(Synthesis Example 15) Production of mixture (B-5) composed of compounds represented by formula (B-5-1) and formula (B-5-2)

Figure 2018025752
Figure 2018025752

合成例12において式(B−2−a)で表される化合物(混合物)をtrans−4−ヒドロキシシクロヘキサンカルボン酸tert−ブチルに、trans−1,4−シクロヘキサンジカルボン酸をtrans−4−(trans−4−エチルシクロヘキシル)シクロヘキサンカルボン酸に置き換えた以外は同様の方法によって、式(B−5−b)で表される化合物を製造した。   In Synthesis Example 12, the compound (mixture) represented by the formula (B-2-a) is converted into tert-butyl trans-4-hydroxycyclohexanecarboxylate, and trans-1,4-cyclohexanedicarboxylic acid is converted into trans-4- (trans A compound represented by the formula (B-5-b) was produced in the same manner except that it was replaced with (-4-ethylcyclohexyl) cyclohexanecarboxylic acid.

反応容器に式(B−5−b)で表される化合物5.0g、ジクロロメタン25mL、ギ酸25mLを加え40℃で10時間加熱撹拌した。溶媒を留去しジイソプロピルエーテルで分散洗浄することによって式(B−5−c)で表される化合物3.9gを得た。   To the reaction vessel were added 5.0 g of the compound represented by the formula (B-5-b), 25 mL of dichloromethane, and 25 mL of formic acid, and the mixture was heated and stirred at 40 ° C. for 10 hours. The solvent was distilled off and dispersed and washed with diisopropyl ether to obtain 3.9 g of a compound represented by the formula (B-5-c).

合成例11においてtrans−4−(trans−4−プロピルシクロヘキシル)シクロヘキサンカルボン酸を式(B−5−c)で表される化合物に置き換えた以外は同様の方法によって、式(B−5)で表される化合物を製造した。
LCMS:m/z 697[M+1]
(合成例16)式(B−6−1)及び式(B−6−2)で表される化合物によって構成される混合物(B−6)の製造
In the same manner as in Synthesis Example 11, except that trans-4- (trans-4-propylcyclohexyl) cyclohexanecarboxylic acid is replaced by a compound represented by the formula (B-5-c), the formula (B-5) is used. The compound represented was prepared.
LCMS: m / z 697 [M + 1]
(Synthesis Example 16) Production of mixture (B-6) composed of compounds represented by formula (B-6-1) and formula (B-6-2)

Figure 2018025752
Figure 2018025752

特開平11−147853号公報に記載の方法によって、式(B−6−b)で表される化合物を製造した。合成例9において式(A−9−c)で表される化合物を式(B−6−a)で表される化合物に、4−ヒドロキシベンズアルデヒドを式(B−6−b)で表される化合物に置き換えた以外は同様の方法によって、式(B−6)で表される化合物を製造した。
LCMS:m/z 543[M+1]
(合成例17)式(C−1)で表される化合物の製造
A compound represented by the formula (B-6-b) was produced by the method described in JP-A-11-147853. In Synthesis Example 9, the compound represented by the formula (A-9-c) is represented by the compound represented by the formula (B-6-a), and 4-hydroxybenzaldehyde is represented by the formula (B-6-b). A compound represented by the formula (B-6) was produced by the same method except that the compound was replaced.
LCMS: m / z 543 [M + 1]
Synthesis Example 17 Production of Compound Represented by Formula (C-1)

Figure 2018025752
Figure 2018025752

合成例1において式(A−1−a)で表される化合物を式(C−1−a)で表される化合物に置き換えた以外は同様の方法によって、式(C−1−d)で表される化合物を製造した。   In the same manner as in Synthesis Example 1, except that the compound represented by the formula (A-1-a) is replaced by the compound represented by the formula (C-1-a), the formula (C-1-d) The compound represented was prepared.

反応容器に式(C−1−d)で表される化合物5.0g、テトラヒドロフラン20mL、メタノール20mL、濃塩酸0.2mLを加え室温で8時間撹拌した。酢酸エチルで希釈した後、水及び食塩水で洗浄した。カラムクロマトグラフィー(シリカゲル、ヘキサン/酢酸エチル)により精製を行い、式(C−1−e)で表される化合物3.7gを得た。   To the reaction vessel were added 5.0 g of the compound represented by the formula (C-1-d), 20 mL of tetrahydrofuran, 20 mL of methanol, and 0.2 mL of concentrated hydrochloric acid, and the mixture was stirred at room temperature for 8 hours. After diluting with ethyl acetate, it was washed with water and brine. Purification was performed by column chromatography (silica gel, hexane / ethyl acetate) to obtain 3.7 g of a compound represented by the formula (C-1-e).

窒素雰囲気下、反応容器に式(C−1−e)で表される化合物3.7g、ジイソプロピルエチルアミン1.6g、ジクロロメタン40mLを加えた。氷冷しながら塩化アクリロイル1.0gを滴下し室温で6時間撹拌した。反応液を水に注ぎ、分液処理した後、1%塩酸及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(C−1)で表される化合物2.9gを得た。
LCMS:m/z 837[M+1]
(合成例18)式(C−2)で表される化合物の製造
Under a nitrogen atmosphere, 3.7 g of the compound represented by the formula (C-1-e), 1.6 g of diisopropylethylamine, and 40 mL of dichloromethane were added to the reaction vessel. While cooling with ice, 1.0 g of acryloyl chloride was added dropwise and stirred at room temperature for 6 hours. The reaction solution was poured into water and subjected to a liquid separation treatment, and then washed sequentially with 1% hydrochloric acid and brine. Purification was performed by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) to obtain 2.9 g of a compound represented by the formula (C-1).
LCMS: m / z 837 [M + 1]
Synthesis Example 18 Production of compound represented by formula (C-2)

Figure 2018025752
Figure 2018025752

合成例17において式(C−1−a)で表される化合物を式(C−2−a)で表される化合物に置き換えた以外は同様の方法によって、式(C−2)で表される化合物を製造した。
LCMS:m/z 837[M+1]
(合成例19)式(C−3)で表される化合物の製造
A compound represented by the formula (C-2) was synthesized in the same manner as in Synthesis Example 17 except that the compound represented by the formula (C-1-a) was replaced with a compound represented by the formula (C-2-a). A compound was prepared.
LCMS: m / z 837 [M + 1]
Synthesis Example 19 Production of compound represented by formula (C-3)

Figure 2018025752
Figure 2018025752

窒素雰囲気下、反応容器に式(C−3−a)で表される化合物5.0g、ジイソプロピルエチルアミン6.0g、ジクロロメタン40mLを加えた。氷冷しながら塩化アクリロイル3.1gを滴下し室温で6時間撹拌した。反応液を水に注ぎ、分液処理した後、1%塩酸及び食塩水で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ヘキサン/酢酸エチル)により精製を行い、式(C−3−b)で表される化合物5.3gを得た。   Under a nitrogen atmosphere, 5.0 g of the compound represented by the formula (C-3-a), 6.0 g of diisopropylethylamine, and 40 mL of dichloromethane were added to the reaction vessel. While cooling with ice, 3.1 g of acryloyl chloride was added dropwise and stirred at room temperature for 6 hours. The reaction solution was poured into water and subjected to a liquid separation treatment, and then washed sequentially with 1% hydrochloric acid and brine. Purification was performed by column chromatography (silica gel, hexane / ethyl acetate) to obtain 5.3 g of a compound represented by the formula (C-3-b).

反応容器に式(C−3−b)で表される化合物5.3g、テトラヒドロフラン20mL、メタノール20mL、濃塩酸0.2mLを加え室温で8時間撹拌した。酢酸エチルで希釈した後、水及び食塩水で洗浄した。カラムクロマトグラフィー(シリカゲル、ヘキサン/酢酸エチル)により精製を行い、式(C−3−c)で表される化合物2.9gを得た。   To the reaction vessel were added 5.3 g of the compound represented by the formula (C-3-b), 20 mL of tetrahydrofuran, 20 mL of methanol, and 0.2 mL of concentrated hydrochloric acid, and the mixture was stirred at room temperature for 8 hours. After diluting with ethyl acetate, it was washed with water and brine. Purification by column chromatography (silica gel, hexane / ethyl acetate) gave 2.9 g of the compound represented by the formula (C-3-c).

合成例1において式(A−1−a)で表される化合物(混合物)を式(C−3−c)で表される化合物に置き換えた以外は同様の方法によって、式(C−3)で表される化合物を製造した。
LCMS:m/z 837[M+1]
(合成例20)式(C−4)で表される化合物の製造
In the same manner as in Synthesis Example 1 except that the compound (mixture) represented by the formula (A-1-a) was replaced with the compound represented by the formula (C-3-c), the formula (C-3) The compound represented by these was manufactured.
LCMS: m / z 837 [M + 1]
Synthesis Example 20 Production of Compound Represented by Formula (C-4)

Figure 2018025752
Figure 2018025752

合成例19において式(C−3−a)で表される化合物を式(C−4−a)で表される化合物に置き換えた以外は同様の方法によって、式(C−4)で表される化合物を製造した。
LCMS:m/z 837[M+1]
(合成例21)式(A−11−1)から式(A−11−4)で表される化合物によって構成される混合物(A−11)の製造
A compound represented by the formula (C-4) was synthesized in the same manner as in Synthesis Example 19 except that the compound represented by the formula (C-3-a) was replaced with a compound represented by the formula (C-4-a). A compound was prepared.
LCMS: m / z 837 [M + 1]
(Synthesis example 21) Manufacture of the mixture (A-11) comprised by the compound represented by Formula (A-11-4) from Formula (A-11-1).

Figure 2018025752
Figure 2018025752

合成例7と同様の方法によって、式(A−11−a)で表される化合物(混合物)を製造した。   A compound (mixture) represented by the formula (A-11-a) was produced in the same manner as in Synthesis Example 7.

反応容器に式(A−11−a)で表される化合物(混合物)5.0g、2,6−ジ−tert−ブチル−4−メチルフェノール7mg、酢酸エチル35mL、N,N−ジメチルアセトアミド14mLを加えた。5℃に冷却し塩化チオニル1.4gを滴下し5℃で1時間撹拌した。N,N−ジイソプロピルエチルアミン2.0gを滴下した。トリメチルヒドロキノン0.8gをテトラヒドロフラン5mLに溶解させた溶液及びN,N−ジメチルアミノピリジン0.2gを加えた。5℃でN,N−ジイソプロピルエチルアミン4.7gを滴下し室温で5時間撹拌した。反応液を水に注ぎ、ジクロロメタンで抽出した後、5%塩酸、水及び食塩水で順次で順次洗浄した。カラムクロマトグラフィー(シリカゲル、ジクロロメタン)及び再結晶(ジクロロメタン/メタノール)により精製を行い、式(A−11)で表される化合物(混合物)4.5gを得た。
LCMS:m/z 1125[M+1]
(実施例1〜156、比較例1〜16)
合成例1から合成例21記載の式(A−1)から式(C−4)で表される化合物及び/又は混合物、特許文献1に記載の化合物(R−1)、特許文献2に記載の化合物(R−2)を評価対象とした。
In a reaction vessel, 5.0 g of the compound (mixture) represented by the formula (A-11-a), 7 mg of 2,6-di-tert-butyl-4-methylphenol, 35 mL of ethyl acetate, 14 mL of N, N-dimethylacetamide Was added. The mixture was cooled to 5 ° C., 1.4 g of thionyl chloride was added dropwise, and the mixture was stirred at 5 ° C. for 1 hour. 2.0 g of N, N-diisopropylethylamine was added dropwise. A solution prepared by dissolving 0.8 g of trimethylhydroquinone in 5 mL of tetrahydrofuran and 0.2 g of N, N-dimethylaminopyridine were added. At 5 ° C., 4.7 g of N, N-diisopropylethylamine was added dropwise and stirred at room temperature for 5 hours. The reaction solution was poured into water, extracted with dichloromethane, and then washed sequentially with 5% hydrochloric acid, water and brine. Purification was performed by column chromatography (silica gel, dichloromethane) and recrystallization (dichloromethane / methanol) to obtain 4.5 g of a compound (mixture) represented by the formula (A-11).
LCMS: m / z 1125 [M + 1]
(Examples 1 to 156, Comparative Examples 1 to 16)
A compound and / or a mixture represented by formula (A-1) to formula (C-4) described in Synthesis Example 1 to Synthesis Example 21, a compound (R-1) described in Patent Document 1, and described in Patent Document 2 The compound (R-2) was evaluated.

Figure 2018025752
Figure 2018025752

その他の2官能重合性化合物として、下記の式(D−1)から式(D−12)で表される化合物を、その他の単官能重合性化合物として、下記の式(E−1)から式(E−8)で表される化合物を、その他のキラル化合物として、下記の式(F−1)から式(F−3)、式(F−5)から式(F−7)で表される化合物及び化合物(F−4)としてLC756(BASF社製)を、その他の添加剤として、下記の式(G−1)から式(G−3)で表される化合物及び化合物(G−4)としてポリプロピレン(重量平均分子量1275)を使用した。   As other bifunctional polymerizable compounds, compounds represented by the following formulas (D-1) to (D-12) are used, and as other monofunctional polymerizable compounds, the following formulas (E-1) to formulas are used. The compounds represented by (E-8) are represented by the following formulas (F-1) to (F-3) and formulas (F-5) to (F-7) as other chiral compounds. As compounds and compound (F-4), LC756 (manufactured by BASF) is used, and as other additives, compounds represented by the following formulas (G-1) to (G-3) and compounds (G-4) ) Polypropylene (weight average molecular weight 1275) was used.

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

撹拌装置を備えた遮光反応装置に、下表に記載の組成比で上記の式(A−1−1)から式(F−7)で表される化合物及び/又は混合物を添加した各組成物100部、メチルエチルケトン300部、シクロヘキサノン100部、p−メトキシフェノール0.1部、IRGACURE819(BASF社製)2部、及び、下記の式(G−1)から式(G−3)で表される化合物又は化合物(G−4)としてポリプロピレン(重量平均分子量1275)を下表に記載の重量部添加し、50℃で1時間加熱撹拌することによって、実施例1〜156、比較例1〜16に用いる重合性組成物の塗布液をそれぞれ得た。   Each composition which added the compound and / or mixture which were represented to said Formula (A-1-1) to Formula (F-7) by the composition ratio as described in the following table to the light-shielding reaction apparatus provided with the stirring apparatus. 100 parts, 300 parts of methyl ethyl ketone, 100 parts of cyclohexanone, 0.1 part of p-methoxyphenol, 2 parts of IRGACURE819 (manufactured by BASF), and the following formulas (G-1) to (G-3) As a compound or a compound (G-4), polypropylene (weight average molecular weight 1275) is added in parts by weight as shown in the table below, and the mixture is heated and stirred at 50 ° C. for 1 hour, to Examples 1 to 156 and Comparative Examples 1 to 16. A coating solution for the polymerizable composition to be used was obtained.

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

ラビング処理したPET上に、重合性組成物の塗布液を室温でバーコーター#4を使用して塗布した後、80℃で2分乾燥した。その後、室温で2分放置した後に、UV照射(500mJ/cm)を行った。得られたフィルムについて、偏光顕微鏡観察によって配向欠陥を評価した。塗布膜を縦10マス×横10マス、計100マスの領域に区分し、配向欠陥の生じたマス目の数をカウントした。値が小さいほど、配向欠陥が少ないことを意味する。結果を下表に示す。 A coating solution of the polymerizable composition was applied on the rubbed PET at room temperature using a bar coater # 4, and then dried at 80 ° C. for 2 minutes. Then, after leaving at room temperature for 2 minutes, UV irradiation (500 mJ / cm 2 ) was performed. About the obtained film, the orientation defect was evaluated by polarizing microscope observation. The coating film was divided into an area of 10 squares × 10 squares, for a total of 100 squares, and the number of squares in which orientation defects occurred was counted. It means that there are few orientation defects, so that a value is small. The results are shown in the table below.

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

表より、本願発明の光学フィルムは比較例の光学フィルムと比較し、配向欠陥が少ないことがわかる。次に、各光学フィルムに対し120℃で5時間加熱処理を行った。実施例1から実施例48及び比較例1から比較例4で得られたコレステリック配向を有する光学フィルムについて、加熱処理前後における選択反射波長の中心値の変化量の絶対値を計測した。また、実施例49から実施例78及び比較例5から比較例8で得られたホモジニアス配向を有する光学フィルムについて、加熱処理前後における位相差Reの変化量の絶対値を測定した。結果を下表に示す。   From the table, it can be seen that the optical film of the present invention has fewer alignment defects than the optical film of the comparative example. Next, each optical film was heat-treated at 120 ° C. for 5 hours. For the optical films having the cholesteric orientation obtained in Example 1 to Example 48 and Comparative Example 1 to Comparative Example 4, the absolute value of the change amount of the central value of the selective reflection wavelength before and after the heat treatment was measured. For the optical films having homogeneous orientation obtained in Examples 49 to 78 and Comparative Examples 5 to 8, the absolute value of the change amount of the phase difference Re before and after the heat treatment was measured. The results are shown in the table below.

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

Figure 2018025752
Figure 2018025752

表より、本願発明の光学フィルムは比較例の光学フィルムと比較し、加熱処理後の選択反射波長の変化量又は位相差の変化量が少ないことがわかる。以上の結果から、本願発明の光学フィルムは配向欠陥が少なく、高温状態に置かれた場合に光学特性の変化が生じにくいことから、表示装置用途の位相差フィルム、選択反射フィルム等として有用である。   From the table, it can be seen that the optical film of the present invention has a smaller amount of change in the selective reflection wavelength or phase difference after the heat treatment than the optical film of the comparative example. From the above results, the optical film of the present invention has few alignment defects, and hardly changes in optical characteristics when placed in a high temperature state. Therefore, it is useful as a retardation film, a selective reflection film, etc. for display devices. .

Claims (15)

下記の一般式(I)
Figure 2018025752
(式中、Pは下記の式(P−1)から式(P−20)
Figure 2018025752
から選ばれる基を表し、
S1は1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子又は塩素原子に置換されても良く、
Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、
k1は0から10の整数を表し、
n11及びn12は各々独立して0から8の整数を表し、
は水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、イソシアノ基、チオイソシアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、Rは下記の式(I−R2)
Figure 2018025752
(式中、Pは上記の式(P−1)から式(P−20)から選ばれる基を表し、
S2は1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子又は塩素原子に置換されても良く、
Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、
k2は0から10の整数を表し、
n21及びn22は各々独立して0から8の整数を表す。)で表される基を表し、
は下記の式(I−M1)
Figure 2018025752
(式中、A及びAは各々独立して1,4−フェニレン基、1,4−シクロヘキシレン基、ビシクロ[2.2.2]オクタン−1,4−ジイル基、ピリジン−2,5−ジイル基、ピリミジン−2,5−ジイル基、ナフタレン−2,6−ジイル基、ナフタレン−1,4−ジイル基、テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基又は1,3−ジオキサン−2,5−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良いが、Aが複数存在する場合それらは同一であっても異なっていても良く、Lはフッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、ニトロ基、シアノ基、イソシアノ基、アミノ基、ヒドロキシル基、メルカプト基、メチルアミノ基、ジメチルアミノ基、ジエチルアミノ基、ジイソプロピルアミノ基、トリメチルシリル基、ジメチルシリル基、チオイソシアノ基、又は、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子に置換されても良く、若しくは、Lは下記の式(I−RL)
Figure 2018025752
(式中、Pは上記の式(P−1)から式(P−20)から選ばれる基を表し、RSLは1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−CH=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表すが、当該アルキル基中の任意の水素原子はフッ素原子又は塩素原子に置換されても良く、Spは炭素原子数1から20のアルキレン基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、Xは−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、kLは0から10の整数を表し、nL1及びnL2は各々独立して0から8の整数を表す。)で表される基を表すが、化合物内にLが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CHCH−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−OCO−NH−、−NH−COO−、−NH−CO−NH−、−NH−O−、−O−NH−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−、−N=CH−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Zが複数存在する場合それらは同一であっても異なっていても良く、
m1は0から5の整数を表す。)で表される基を表す。)で表される化合物に由来する構造単位を含有する光学フィルム。
The following general formula (I)
Figure 2018025752
(In the formula, P 1 is the following formula (P-1) to formula (P-20)
Figure 2018025752
Represents a group selected from
In R S1 , one —CH 2 — or two or more non-adjacent —CH 2 — are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO. -S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH A linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by ═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— or —C≡C— In which any hydrogen atom in the alkyl group may be substituted with a fluorine atom or a chlorine atom,
Sp 1 represents an alkylene group having 1 to 20 carbon atoms, and when a plurality of Sp 1 are present, they may be the same or different,
X 1 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO. -O -, - CO-NH - , - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, — CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH- , -N = N -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, X 1 is more present They may be different even in the same case that,
k1 represents an integer of 0 to 10,
n11 and n12 each independently represents an integer of 0 to 8,
R 2 is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a pentafluorosulfuranyl group, a cyano group, a nitro group, an isocyano group, a thioisocyano group, or any hydrogen atom in the group is a fluorine atom. One —CH 2 — or two or more non-adjacent —CH 2 — may be each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—, —NH—CO—, —SCH 2 —, — CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH— , -OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 C 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - Linear or branched having 1 to 20 carbon atoms which may be substituted by CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C— Represents an alkyl group, or R 2 represents the following formula (I-R2)
Figure 2018025752
(Wherein P 2 represents a group selected from the above formulas (P-1) to (P-20);
R S2 represents one —CH 2 — or two or more non-adjacent —CH 2 — each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO. -S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH A linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by ═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— or —C≡C— In which any hydrogen atom in the alkyl group may be substituted with a fluorine atom or a chlorine atom,
Sp 2 represents an alkylene group having 1 to 20 carbon atoms, and when a plurality of Sp 2 are present, they may be the same or different,
X 2 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO. -O -, - CO-NH - , - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, — CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH- , -N = N -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, X 2 is plurality of They may be different even in the same case that,
k2 represents an integer of 0 to 10,
n21 and n22 each independently represents an integer of 0 to 8. ) Represents a group represented by
M 1 is the following formula (I-M1)
Figure 2018025752
(In the formula, A 1 and A 2 are each independently 1,4-phenylene group, 1,4-cyclohexylene group, bicyclo [2.2.2] octane-1,4-diyl group, pyridine-2, 5-diyl group, pyrimidine-2,5-diyl group, naphthalene-2,6-diyl group, naphthalene-1,4-diyl group, tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6- Represents a diyl group or a 1,3-dioxane-2,5-diyl group, these groups may be unsubstituted or substituted by one or more substituents L, but there are multiple A 1 In this case, they may be the same or different, and L is fluorine atom, chlorine atom, bromine atom, iodine atom, pentafluorosulfuranyl group, nitro group, cyano group, isocyano group, amino group, hydroxyl group, Mel Script group, methylamino group, dimethylamino group, diethylamino group, diisopropylamino group, trimethylsilyl group, dimethylsilyl group, Chioisoshiano group, or one -CH 2 - or nonadjacent two or more -CH 2 - Are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NH—. , —NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CH═CH—, —CF═CF— Or a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by -C≡C-, wherein any hydrogen atom in the alkyl group may be substituted by a fluorine atom, Or, L is the following formula (I-RL)
Figure 2018025752
(In the formula, P L represents a group selected from the above formulas (P-1) to (P-20), and R SL represents one —CH 2 — or two or more —CH that are not adjacent to each other. 2- are each independently —O—, —S—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—. NH—, —NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —CH═CH—, —CF═ Represents a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by CF- or -C≡C-, wherein any hydrogen atom in the alkyl group is substituted with a fluorine atom or a chlorine atom may be, Sp L represents an alkylene group having 1 to 20 carbon atoms, they if Sp L there are multiple same A well be different also, X L is -O in -, - S -, - OCH 2 -, - CH 2 O -, - CO -, - COO -, - OCO -, - CO-S-, -S-CO -, - O- CO-O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, -OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH = CH -, - N = N -, - CH = N-N = CH -, - CF = CF -, - C≡C- or Represents a bond, if X L there are a plurality thereof may be different even in the same, kL is an integer from 0 to 10, an integer from 0 independently each nL1 and nL2 8 )), When a plurality of L are present in the compound, they may be the same or different,
Z 1 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -OCO-NH-, -NH-COO-, -NH-CO-NH-, -NH-O-,- O—NH—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH -OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH CH -, - N = N -, - CH = N -, - N = CH -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, Z When there are multiple 1s, they may be the same or different,
m1 represents an integer of 0 to 5. ) Represents a group represented by The optical film containing the structural unit derived from the compound represented by this.
さらに、下記の一般式(II)
Figure 2018025752
(式中、P及びPは各々独立してラジカル重合、カチオン重合又はアニオン重合によって重合する基を表し、
Sp及びSpは各々独立してスペーサー基を表すが、Spが複数存在する場合それらは同一であっても異なっていても良く、Spが複数存在する場合それらは同一であっても異なっていても良く、
及びXは各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Xが複数存在する場合それらは同一であっても異なっていても良く、Xが複数存在する場合それらは同一であっても異なっていても良く、
k3及びk4は各々独立して0から10の整数を表し、
及びAは各々独立して1,4−フェニレン基、1,4−シクロヘキシレン基、ビシクロ[2.2.2]オクタン−1,4−ジイル基、ピリジン−2,5−ジイル基、ピリミジン−2,5−ジイル基、ナフタレン−2,6−ジイル基、ナフタレン−1,4−ジイル基、テトラヒドロナフタレン−2,6−ジイル基、デカヒドロナフタレン−2,6−ジイル基又は1,3−ジオキサン−2,5−ジイル基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良いが、Aが複数存在する場合それらは同一であっても異なっていても良く、
は−O−、−S−、−OCH−、−CHO−、−CHCH−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−OCO−NH−、−NH−COO−、−NH−CO−NH−、−NH−O−、−O−NH−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−、−N=CH−、−CH=N−N=CH−、−CF=CF−、−C≡C−又は単結合を表すが、Zが複数存在する場合それらは同一であっても異なっていても良く、
m2は0から5の整数を表す。)で表される化合物に由来する構造単位を含有する請求項1に記載の光学フィルム。
Furthermore, the following general formula (II)
Figure 2018025752
(Wherein P 3 and P 4 each independently represent a group that is polymerized by radical polymerization, cationic polymerization, or anionic polymerization;
Sp 3 and Sp 4 each independently represent a spacer group. When a plurality of Sp 3 are present, they may be the same or different, and when a plurality of Sp 4 are present, they may be the same. May be different,
X 3 and X 4 are each independently —O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO -, - O-CO- O -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 O -, - OCF 2 -, - CF 2 S- , -SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO- CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO —, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF—, —C≡C— or a single bond. But they if X 3 there are a plurality may be the same or different and they if X 4 there are a plurality may be the same or different and
k3 and k4 each independently represents an integer of 0 to 10,
A 3 and A 4 are each independently 1,4-phenylene group, 1,4-cyclohexylene group, bicyclo [2.2.2] octane-1,4-diyl group, pyridine-2,5-diyl group. , Pyrimidine-2,5-diyl group, naphthalene-2,6-diyl group, naphthalene-1,4-diyl group, tetrahydronaphthalene-2,6-diyl group, decahydronaphthalene-2,6-diyl group or 1 , 3-dioxane-2,5-diyl groups, these groups may be unsubstituted or substituted by one or more substituents L, but they are the same when there are multiple A 3 Can be different,
Z 2 represents —O—, —S—, —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —CO—, —COO—, —OCO—, —CO—S—, —S—. CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -OCO-NH-, -NH-COO-, -NH-CO-NH-, -NH-O-,- O—NH—, —SCH 2 —, —CH 2 S—, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —CH═CH—COO—, —CH═CH -OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2 -, - OCO-CH 2 -, - CH 2 -COO -, - CH 2 -OCO -, - CH CH -, - N = N -, - CH = N -, - N = CH -, - CH = N-N = CH -, - CF = CF -, - C≡C- or represents a single bond, Z When two or more 2 exist, they may be the same or different,
m2 represents an integer of 0 to 5. The optical film of Claim 1 containing the structural unit derived from the compound represented by this.
一般式(I)で表される化合物が下記の一般式(I−A)
Figure 2018025752
(式中、P及びMは各々一般式(I)におけるP及びMと同じ意味を表し、Sp11及びX11は各々一般式(I)におけるSp及びXと同じ意味を表し、n111及びn121は各々独立して0又は1を表すが、n111+n121は1を表し、R21は下記の式(I−R2−A)
Figure 2018025752
(式中、Pは一般式(I)におけるPと同じ意味を表し、Sp21及びX21は各々一般式(I)におけるSp及びXと同じ意味を表し、n211及びn221は各々独立して0又は1を表すが、n211+n221は1を表す。)で表される基を表す。)で表される、請求項1又は請求項2に記載の光学フィルム。
The compound represented by the general formula (I) is represented by the following general formula (IA)
Figure 2018025752
(In the formula, P 1 and M 1 each have the same meaning as P 1 and M 1 in the general formula (I), and Sp 11 and X 11 each have the same meaning as Sp 1 and X 1 in the general formula (I). represents, n111 and n121 represents 0 or 1 each independently is, n111 + n121 represents 1, R 21 is the following formula (I-R2-a)
Figure 2018025752
(Wherein, P 2 has the same meaning as P 2 in formula (I), Sp 21 and X 21 are as defined Sp 2 and X 2 each in the general formula (I), each n211 and n221 Independently represents 0 or 1, but n211 + n221 represents 1.). The optical film of Claim 1 or Claim 2 represented by this.
一般式(I−A)において、n111が0を表し、n121が1を表し、R21が式(I−R2−A)で表される基を表し、n211が1を表し、n221が0を表す、請求項3に記載の光学フィルム。 In the general formula (I-A), n111 represents 0, n121 represents 1 represents a group R 21 is represented by the formula (I-R2-A), n211 represents 1, the n221 is 0 The optical film according to claim 3 represented. 下記の一般式(I−A−11)
Figure 2018025752
(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−22)
Figure 2018025752
(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−12)
Figure 2018025752
(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物と、下記の一般式(I−A−21)
Figure 2018025752
(式中、P、P、Sp11、Sp21、X11、X21及びMは各々一般式(I−A)又は一般式(I−R2−A)におけるP、P、Sp11、Sp21、X11、X21及びMと同じ意味を表す。)で表される化合物に由来する構造単位とを含有する請求項3に記載の光学フィルム。
The following general formula (IA-11)
Figure 2018025752
(In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), A structural unit derived from a compound represented by Sp 11 , Sp 21 , X 11 , X 21 and M 1 ), and the following general formula (IA-22)
Figure 2018025752
(In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), A structural unit derived from a compound represented by Sp 11 , Sp 21 , X 11 , X 21 and M 1 ), and the following general formula (IA-12)
Figure 2018025752
(In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), Sp 11 , Sp 21 , X 11 , X 21 and M 1 represent the same meanings) and the following general formula (IA-21)
Figure 2018025752
(In the formula, P 1 , P 2 , Sp 11 , Sp 21 , X 11 , X 21 and M 1 are respectively P 1 , P 2 in the general formula (IA) or (I-R2-A), the optical film according to sp 11, sp 21, X 11 , X 21 and M 1 represent the same meaning as.) claim 3 containing a structural unit derived from a compound represented by.
下記の一般式(I−A−111)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12及びA21は各々独立して1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z11及びZ12は各々独立して−OCH−、−CHO−、−CHCH−、−COO−、−OCO−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−221)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−121)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−211)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A21、Z11及びZ12は各々一般式(I−A−111)におけるA11、A12、A21、Z11及びZ12と同じ意味を表す。)で表される化合物に由来する構造単位とを含有する請求項3に記載の光学フィルム。
The following general formula (IA-111)
Figure 2018025752
(Wherein, P 1 and P 2 each represent a formula (I-A) or the same meaning as P 1 and P 2 in the general formula (I-R2-A), A 11, A 12 and A 21 are each Independently represents a 1,4-phenylene group or a 1,4-cyclohexylene group, these groups may be unsubstituted or substituted by one or more substituents L, Z 11 and Z 12 Each independently represents —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —COO—, —OCO—, —CO—NH—, —NH—CO—, —CH═CH—COO—. , —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 —, —CH 2 CH 2 —COO -, -. CH 2 CH 2 -OCO- or a single bond) the compound represented by And the following general formula (IA-221)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 each represents the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 in the general formula (IA-111), and a structural unit derived from the following: General formula (IA-121)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 each represents the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 in the general formula (IA-111), and a structural unit derived from the following: General formula (IA-211)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 21 , Z 11 and Z 12 each contain a structural unit derived from a compound represented by the formula (IA-111) having the same meaning as A 11 , A 12 , A 21 , Z 11 and Z 12 ). The optical film according to claim 3.
下記の一般式(I−A−112)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14及びA21は各々独立して1,4−フェニレン基又は1,4−シクロヘキシレン基を表すが、これらの基は無置換であるか又は1つ以上の置換基Lによって置換されても良く、Z11、Z12、Z13及びZ14は各々独立して−OCH−、−CHO−、−CHCH−、−COO−、−OCO−、−CO−NH−、−NH−CO−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−又は単結合を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−222)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−122)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物に由来する構造単位と、下記の一般式(I−A−212)
Figure 2018025752
(式中、P及びPは各々一般式(I−A)又は一般式(I−R2−A)におけるP及びPと同じ意味を表し、A11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14は各々一般式(I−A−112)におけるA11、A12、A13、A14、A21、Z11、Z12、Z13及びZ14と同じ意味を表す。)で表される化合物に由来する構造単位とを含有する請求項3に記載の光学フィルム。
The following general formula (IA-112)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 and A 21 each independently represents a 1,4-phenylene group or a 1,4-cyclohexylene group, but these groups may be unsubstituted or substituted by one or more substituents L. , Z 11 , Z 12 , Z 13 and Z 14 are each independently —OCH 2 —, —CH 2 O—, —CH 2 CH 2 —, —COO—, —OCO—, —CO—NH—, — NH—CO—, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CH 2 CH 2 —, —OCO—CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO Or a single bond. A structural unit derived from the compound represented by), the general formula (I-A-222)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). represents the same meaning as 13 and Z 14. a structural unit derived from the compound represented by), the general formula (I-a-122)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). represents the same meaning as 13 and Z 14. a structural unit derived from the compound represented by), the general formula (I-a-212)
Figure 2018025752
(In the formula, P 1 and P 2 represent the same meaning as P 1 and P 2 in the general formula (IA) or the general formula (I-R2-A), respectively), A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z 13 and Z 14 are respectively A 11 , A 12 , A 13 , A 14 , A 21 , Z 11 , Z 12 , Z in the general formula (IA-112). the optical film according to claim 3 containing a structural unit derived from a compound represented by the representative.) the same meaning as 13 and Z 14.
さらに、キラル化合物に由来する構造単位を含有する請求項1から請求項7のいずれか一項に記載の光学フィルム。   Furthermore, the optical film as described in any one of Claims 1-7 containing the structural unit derived from a chiral compound. コレステリック構造を有する、請求項1から請求項8のいずれか一項に記載の光学フィルム。   The optical film according to any one of claims 1 to 8, which has a cholesteric structure. 一般式(I)で表される化合物が、下記の一般式(I−C)
Figure 2018025752
(式中、P、RS1、n11、n12、Sp、X、k1及びMは各々一般式(I)におけるP、RS1、n11、n12、Sp、X、k1及びMと同じ意味を表し、Cは不斉炭素原子を表し、R2Cは水素原子、フッ素原子、塩素原子、臭素原子、ヨウ素原子、ペンタフルオロスルフラニル基、シアノ基、ニトロ基、イソシアノ基、チオイソシアノ基、又は、基中の任意の水素原子がフッ素原子に置換されても良く、1個の−CH−又は隣接していない2個以上の−CH−が各々独立して−O−、−S−、−OCH−、−CHO−、−CO−、−COO−、−OCO−、−CO−S−、−S−CO−、−O−CO−O−、−CO−NH−、−NH−CO−、−SCH−、−CHS−、−CFO−、−OCF−、−CFS−、−SCF−、−CH=CH−COO−、−CH=CH−OCO−、−COO−CH=CH−、−OCO−CH=CH−、−COO−CHCH−、−OCO−CHCH−、−CHCH−COO−、−CHCH−OCO−、−COO−CH−、−OCO−CH−、−CH−COO−、−CH−OCO−、−CH=CH−、−N=N−、−CH=N−N=CH−、−CF=CF−又は−C≡C−によって置換されても良い炭素原子数1から20の直鎖状又は分岐状アルキル基を表し、若しくは、R2Cは下記の式(I−R2−C)
Figure 2018025752
(式中、P、RS2、n21、n22、Sp、X及びk2は各々一般式(I)におけるP、RS2、n21、n22、Sp、X及びk2と同じ意味を表し、Cは不斉炭素原子を表す。)で表される、請求項1に記載の光学フィルム。
The compound represented by the general formula (I) is represented by the following general formula (IC)
Figure 2018025752
(Wherein, P 1, R S1, n11 , n12, Sp 1, X 1, P 1 in k1 and M 1 are each the general formula (I), R S1, n11 , n12, Sp 1, X 1, k1 and M 1 represents the same meaning, * C represents an asymmetric carbon atom, R 2C represents a hydrogen atom, fluorine atom, chlorine atom, bromine atom, iodine atom, pentafluorosulfuranyl group, cyano group, nitro group, isocyano Group, thioisocyano group, or any hydrogen atom in the group may be substituted with a fluorine atom, and one —CH 2 — or two or more non-adjacent —CH 2 — are each independently — O—, —S—, —OCH 2 —, —CH 2 O—, —CO—, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, -CO-NH -, - NH- CO -, - SCH 2 -, - CH 2 S-, CF 2 O -, - OCF 2 -, - CF 2 S -, - SCF 2 -, - CH = CH-COO -, - CH = CH-OCO -, - COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2 —, —CH 2 —COO—, —CH 2 —OCO—, —CH═CH—, —N═N—, —CH═N—N═CH—, —CF═CF— or —C≡C—. Represents a linear or branched alkyl group having 1 to 20 carbon atoms which may be substituted by R 2C , or R 2C is represented by the following formula (I-R2-C):
Figure 2018025752
(Wherein P 2 , R S2 , n21, n22, Sp 2 , X 2 and k2 have the same meaning as P 2 , R S2 , n21, n22, Sp 2 , X 2 and k2 in the general formula (I), respectively. The optical film according to claim 1, represented by: * C represents an asymmetric carbon atom.
請求項1に記載の一般式(I)で表される化合物。   The compound represented by the general formula (I) according to claim 1. 請求項6に記載の一般式(I−A−111)、一般式(I−A−221)、一般式(I−A−121)又は一般式(I−A−211)で表される化合物。   The compound represented by general formula (IA-111), general formula (IA-221), general formula (IA-121) or general formula (IA-211) according to claim 6. . 請求項7に記載の一般式(I−A−112)、一般式(I−A−222)、一般式(I−A−122)又は一般式(I−A−212)で表される化合物。   The compound represented by general formula (IA-112), general formula (IA-222), general formula (IA-122) or general formula (IA-212) according to claim 7 . 請求項1から請求項10のいずれか一項に記載の光学フィルムを用いた積層フィルム。   The laminated film using the optical film as described in any one of Claims 1-10. 請求項1から請求項10のいずれか一項に記載の光学フィルム又は請求項14に記載の積層フィルムを備えた表示装置。   The display apparatus provided with the optical film as described in any one of Claims 1-10, or the laminated | multilayer film as described in Claim 14.
JP2017113403A 2016-08-03 2017-06-08 Optical anisotropic body Active JP6933004B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/668,235 US10655066B2 (en) 2016-08-03 2017-08-03 Optical isomer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016152889 2016-08-03
JP2016152889 2016-08-03

Publications (2)

Publication Number Publication Date
JP2018025752A true JP2018025752A (en) 2018-02-15
JP6933004B2 JP6933004B2 (en) 2021-09-08

Family

ID=61194849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017113403A Active JP6933004B2 (en) 2016-08-03 2017-06-08 Optical anisotropic body

Country Status (1)

Country Link
JP (1) JP6933004B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019098040A1 (en) * 2017-11-17 2019-05-23 Dic株式会社 Polymerizable compound, and liquid crystal composition and liquid crystal display element using same
US11739270B2 (en) 2018-03-01 2023-08-29 Dic Corporation Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078431A1 (en) * 2007-12-19 2009-06-25 Zeon Corporation Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical isomer
JP2016053149A (en) * 2014-03-28 2016-04-14 富士フイルム株式会社 Polymerizable compound, polymer, polymerizable composition, film, and half mirror for projection image display
US20160108315A1 (en) * 2014-10-21 2016-04-21 Fujifilm Corporation Optically anisotropic layer, method for producing the optically anisotropic layer, a laminate, polarizing plate, display device, liquid crystal compound, method for producing the liquid crystal compound, and carboxylic acid compound
WO2017057545A1 (en) * 2015-09-30 2017-04-06 富士フイルム株式会社 Optical film, polarizing plate, and image display device
WO2017090644A1 (en) * 2015-11-26 2017-06-01 富士フイルム株式会社 Optical film, polarizing plate, image display device, polymerizable compound and 1,4-cyclohexane dicarboxylic acid mono aryl ester production method
WO2017170443A1 (en) * 2016-03-30 2017-10-05 富士フイルム株式会社 Optical film, polarizing plate, and image display device
JP2018016577A (en) * 2016-07-27 2018-02-01 富士フイルム株式会社 Ester compound production method
JP2018025770A (en) * 2016-07-28 2018-02-15 富士フイルム株式会社 Method for manufacturing liquid crystal mixture

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078431A1 (en) * 2007-12-19 2009-06-25 Zeon Corporation Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical isomer
JP2016053149A (en) * 2014-03-28 2016-04-14 富士フイルム株式会社 Polymerizable compound, polymer, polymerizable composition, film, and half mirror for projection image display
US20160108315A1 (en) * 2014-10-21 2016-04-21 Fujifilm Corporation Optically anisotropic layer, method for producing the optically anisotropic layer, a laminate, polarizing plate, display device, liquid crystal compound, method for producing the liquid crystal compound, and carboxylic acid compound
WO2017057545A1 (en) * 2015-09-30 2017-04-06 富士フイルム株式会社 Optical film, polarizing plate, and image display device
WO2017090644A1 (en) * 2015-11-26 2017-06-01 富士フイルム株式会社 Optical film, polarizing plate, image display device, polymerizable compound and 1,4-cyclohexane dicarboxylic acid mono aryl ester production method
WO2017170443A1 (en) * 2016-03-30 2017-10-05 富士フイルム株式会社 Optical film, polarizing plate, and image display device
JP2018016577A (en) * 2016-07-27 2018-02-01 富士フイルム株式会社 Ester compound production method
JP2018025770A (en) * 2016-07-28 2018-02-15 富士フイルム株式会社 Method for manufacturing liquid crystal mixture

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019098040A1 (en) * 2017-11-17 2019-05-23 Dic株式会社 Polymerizable compound, and liquid crystal composition and liquid crystal display element using same
US11760934B2 (en) 2017-11-17 2023-09-19 Dic Corporation Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used
US11739270B2 (en) 2018-03-01 2023-08-29 Dic Corporation Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound

Also Published As

Publication number Publication date
JP6933004B2 (en) 2021-09-08

Similar Documents

Publication Publication Date Title
JP5103774B2 (en) Polymerizable chiral compound
JP5510045B2 (en) Polymerizable compound and polymer thereof
JP4961795B2 (en) Polymerizable chiral compound
JP4617838B2 (en) Liquid crystalline (meth) acrylate derivatives and compositions containing them
JP5168976B2 (en) Biphenyl and terphenyl compounds and polymerizable liquid crystal compositions containing the compounds
JP4576832B2 (en) Polymerizable compound and polymer thereof
JP5531475B2 (en) Polymerizable chiral compound
WO2017068860A1 (en) Polymerizable compound and optically anisotropic body
JP5509678B2 (en) Polymerizable compound and polymerizable composition using the compound
JP5505686B2 (en) Polymerizable biphenyl compound
US7101595B2 (en) Photo-curable fluorene derivative and composition containing the same
JP4561218B2 (en) Photocurable fluorene derivatives and compositions containing them
JP2008100982A (en) Trifunctional compound, composition and polymer thereof
JP2011084477A (en) Polymerizable naphthalene compound
JP5288156B2 (en) Polymerizable chiral compound
WO2012144331A1 (en) Polymerizable compound having lateral substituent group at terminal ring structure
JP4924865B2 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition and polymer thereof
JP5396815B2 (en) Polymerizable compound, polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
JP2011184417A (en) Polymerizable acetylene compound
JP5040259B2 (en) Lateral α-substituted acrylate compound and polymer thereof
JP2006225463A (en) Tetrahydroxybenzene tetraester derivative and its polymer
JP6933004B2 (en) Optical anisotropic body
JP6418476B1 (en) Polymerizable compound and optical anisotropic body
JP2010222280A (en) Polymerizable biphenyl compound
JP4415818B2 (en) Polymerizable triptycene derivative

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20180220

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20190620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200407

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210511

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210720

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210802

R151 Written notification of patent or utility model registration

Ref document number: 6933004

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154